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ABSTRACT 
Toward a General Dehydrogenase Enzymatic 
Scaffold for Industrial Biocatalysis 
Elliot T. Campbell 
 
Enzymes catalyze a wide range of reactions with high efficiency and exquisite 
specificity. As such, they lend themselves well for use in a myriad of applications 
from the production of fine chemicals to use in biofuel cells. Demand for enzymes 
with novel specificities has risen in recent years, as they are “green” catalysts and 
may find use as environmentally friendly replacements for conventional catalysts 
in a variety of chemical processes. However, their widespread use has been 
hindered by a number of challenges, including high cost, low stability, and the 
requirement of expensive cofactors for catalysis. A significant amount of research 
has been done to address these limitations, but the approaches taken are rarely 
general, and thus it remains difficult to engineer industrially compatible enzymes.  
The ideal enzyme for use in these systems would be inexpensive to express and 
purify, extremely stable, easy to immobilize without loss of activity, able to use 
cheap, non-natural cofactors with improved stabilities and redox properties, and 
be rapidly evolvable for desired substrate specificities and reactions. Here, we 
  
present a novel approach to satisfy these requirements. We begin with a designed 
enzyme scaffold with beneficial properties for use in these systems, and then 
engineer in cofactor and substrate specificity as required for the application. 
A thermostable alcohol dehydrogenase, AdhD, from the hyperthermophilic 
archaea Pyrococcus furiosus was selected as the scaffold for this work, as it 
possesses several features which make it an attractive candidate for protein 
engineering and downstream industrial applications. It can be expressed 
recombinantly in Escherichia coli in high yield, and is readily purified due to its 
extreme thermostability (half-life of 130 min at 100°C). Additionally, a 
thermostable scaffold will increase enzyme lifetimes in industrial applications, and 
provide resistance to chemical and thermal inactivation. AdhD belongs to the 
aldo-keto reductase superfamily, a large and diverse family of oxidoreductase 
enzymes, and shares the canonical (α/β)8-barrel fold and nicotinamide cofactor 
binding pocket. AdhD has a strong preference for NAD(H) over NADP(H), and is 
active with a broad range of substrates. Lastly, the enzyme is monomeric, with no 
metal centers or disulfides, further simplifying engineering efforts.  
We began by examining cofactor binding in the AdhD enzyme through several 
rational mutations to the cofactor binding pocket. Guided by previous work 
examining cofactor specificity in the aldo-keto reductase superfamily, we 
  
identified two mutations, K249G and H255R, which had a significant impact on 
cofactor binding and activity.  
While characterizing the cofactor specificity double mutant, we discovered that the 
mutations also enabled the enzyme to utilize a truncated nicotinamide cofactor for 
catalysis. The benefit of improved cofactor diffusion was demonstrated through 
the creation of an enzymatic biofuel cell for the oxidation of D-arabinose.  
Next we examined the substrate specificity of the enzyme, utilizing a rational loop-
swapping approach. AdhD was readily imparted with aldose reductase activity 
through the grafting of substrate binding loops from another AKR, human aldose 
reductase. The chimeric loop mutants also retained activity with the model 
substrate for AdhD, but exhibited a complete reversal of cofactor specificity. 
Finally, we discuss the design and preliminary results of a novel selection step for 
the directed evolution of substrate specificity and catalytic activity. Taken 
together, this work describes the development of a general dehydrogenase 
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The field of enzyme engineering has evolved rapidly over the past 30 years, due in part 
to the growing demand for enzymes to replace conventional catalysts in industrial 
applications (Table 1.1). The worldwide market for industrial enzymes was estimated at 
$3.3 billion in 2010, with strong growth projected over the next decade (1). Enzymes are 
attractive alternatives to conventional catalysts, as they are derived from natural 
sources, work under mild conditions, and exhibit extremely high catalytic efficiency 
and selectivity (2). However, the use of natural enzymes in industrial applications is 
often hindered by their high cost, limited stability, strict cofactor requirements, and the 
limited number of reactions catalyzed by known enzymes. To address these limitations, 
researchers have developed a range of techniques to study enzyme function and 
mechanism, and to enable the engineering of enzymes with desirable properties. 
 
Cofactor Specificity 
Many industrially important enzymes require a cofactor for catalysis. The most 
common cofactors are nicotinamide adenine dinucleotide (phosphate) (NAD(P)(H)) and 
flavin adenine mononucleotide/dinucleotide (FMN(H)/FAD(H)). These cofactors 
 2 
perform the function of electron donor or acceptor in dehydrogenase or reductase 
enzymatic reactions, and thus are required for activity. The nicotinamide cofactors 
NAD(H) and NADP(H) differ only by the presence of a 2’-phosphate group on the 
adenine ribose. Enzymes have evolved the ability to discriminate between these two 
cofactors so that both reduction and oxidation reactions can take place simultaneously 
within the cell. The physiological ratios of cofactors are [NADP(H)] > [NADP+] and 
[NAD+] > [NADH] (3). Thus enzymes that prefer NADP(H) generally act as reductases, 
while those that prefer NAD(H) act as oxidases.  
The first reported alteration of cofactor specificity was by Scrutton et al. who utilized 
site-directed mutagenesis to alter the cofactor preference of glutathione reductase from 
NADP+ to NAD+ (4). Seven mutations were identified in the “fingerprint” region of the 
cofactor binding βαβ-fold motif to reverse cofactor specificity and result in a marked 
preference for NAD+ as a cofactor. Since this pioneering work, there have been 
numerous reports of the alteration of cofactor specificity in a wide range of enzymes 
utilizing several different cofactor binding motifs (5-11). A review of cofactor 
engineering in the aldo-keto reductase superfamily appears later in this chapter. 
Traditionally, cofactor engineering is undertaken to address a cofactor imbalance in a 
process, or to increase activity with the less expensive cofactor NAD(H). There have 
also been a few attempts at engineering specificity for non-natural cofactors, with mixed 
results. Our efforts to broaden the nicotinamide cofactor specificity in a dehydrogenase 
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are discussed in Chapter 3, and we examine specificity for non-natural cofactors in 
Chapter 4.  
 
Substrate Specificity 
Altering the substrate specificity of enzymes was one of the primary goals of early 
enzyme engineering efforts. While an immense number of enzymes have been 
identified, very few natively exhibit high levels of activity with industrially relevant or 
desirable substrates. As such, a significant amount of research has been devoted to 
elucidating the determinants of substrate specificity and in engineering enzymes for 
improved activity with various substrates. A wide range of enzymes have been 
successfully engineered in this regard, including proteases (12, 13), nucleases (14), 
hydrolases (15), and many others (16, 17). While much has been learned through 
rational engineering approaches to altering substrate specificity, more recent efforts 
have taken advantage of directed evolution techniques to identify beneficial mutations. 
A major limitation to these approaches is that, except in some specialized cases, mutants 
must be screened individually for the desired substrate specificity and activity. New 
techniques are constantly being developed, but a general and rapid method for creating 
enzymes with desired specificities remains elusive. A review of the approaches used to 
engineer novel substrate specificities appears in Chapter 6.  
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Enzyme Stability 
Proteins have evolved to be only marginally stable in their native environment. It was 
once thought this was due to positive selection for increased activities of more flexible, 
and therefore less stable, proteins but it has since been suggested that the marginal 
stability is an artifact of neutral genetic drift and lack of selective pressure for increased 
stability (18). Regardless, wild-type enzymes are generally only slightly more stable 
than their parent organisms, and this low stability can lead to reduced lifetimes in 
industrial applications. For example an important class of industrial enzymes, lipases, 
are generally isolated from cold-adapted species and are therefore extremely 
thermolabile (19, 20). Various rational design and directed evolution approaches have 
been used to stabilize these enzymes against thermal or chemical denaturation, with 
moderate success (21, 22). Interestingly, it has been observed that directed evolution 
approaches generally yield superior results, as stabilizing mutations are not always 
easy to rationalize. This is well illustrated in the aldo-keto reductase superfamily, as 
Pyrococcus furiosus AdhD is extremely thermostable yet shares the same canonical 
tertiary structure as other mesostable AKRs. The difference is that AdhD contains 
numerous stabilizing mutations throughout the enzyme, and exhibits as low as 30% 




Due to their high cost, the use of soluble proteins and enzymes in industrial 
applications is generally avoided. Instead, it is preferable to immobilize enzymes on 
some sort of solid support to facilitate separation and reuse. This immobilization can be 
as simple as absorption onto a surface, or may involve covalent linkages such as 
glutaraldehyde cross-linking, attachment through cysteines, or genetic fusion to a 
binding protein (23). The use of various polymers as immobilization matrices, such as 
chitosan or Nafion®, has also been investigated with good success (24, 25). Lastly, 
proteins and enzymes have been engineered themselves for self-assembly through the 
genetic fusion of various proteinaceous cross-linking domains. 
Each of these immobilization strategies has advantages and disadvantages, but the 
primary concern is the impact of immobilization on enzymatic activity. Adsorption of 
the enzyme onto a surface or chemically-induced cross-linking may disrupt the native 
tertiary fold of the enzyme and lead to inactivity. Similarly, attachment through 
cysteines or fusion to another protein domain may block the active site. To address this 
problem, our lab has developed a general method for the immobilization of enzymes 
through the fusion of α-helical leucine zipper domains (26). These domains form non-
covalent cross-links under mild conditions through the formation of tetrameric coiled-
coil bundles. Furthermore, mixed macrohomogenous hydrogels are readily constructed 
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due to the general nature of this immobilization approach, and this could find utility in 
the creation of synthetic metabolic pathways. We have shown that this immobilization 
strategy can be extended to the AdhD enzyme, and the result is a thermostable 
enzymatically active hydrogel that retains its materials properties at temperatures in 
excess of 60°C (27). The design and construction of this bioactive hydrogel is discussed 
in Chapter 2. 
 
The Aldo-Keto Reductase Superfamily 
The aldo-keto reductase (AKR) superfamily consists of monomeric oxidoreductase 
enzymes approximately 300 residues in size. They share a common (α/β)8-barrel tertiary 
structure and bind a nicotinamide cofactor without a Rossman-fold motif (28). AKRs 
appear in every living system, and catalyze an array of redox reactions involving a 
broad range of substrates (29). As such, these enzymes are of significant physiological 
importance and much work has been done to characterize their structures, substrate 
specificities, and reaction mechanism.  
Sequence alignments of AKRs have revealed that the residues that make up the cofactor 
binding pocket and active site are highly conserved amongst members, while the 
substrate binding loops vary significantly. Thus it seems all AKRs share the same 
catalytic mechanism while tailoring substrate specificity through modification of the 
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loops near the active site. The highly conserved nature of the cofactor binding pocket 
and active site is useful in identifying putative members of the AKR superfamily, even 
though some members may exhibit less than 30% sequence homology overall (28, 30).  
The catalytic mechanism of the AKRs has been elucidated through numerous site-
directed mutations within the active site. The enzyme family has been shown to follow 
an ordered bi-bi reaction mechanism, with the cofactor binding first and leaving last 
(31). Catalysis involves direct hydride ion transfer between the 4-pro-R position of the 
nicotinamide ring C-4 directly to the re face of the substrate (31).  There is some debate 
as to which active site residue serves as a general acid/base to accomplish proton 
transfer, however. Most evidence points to Tyr-55, as salt-bridges and hydrogen bonds 
formed by Asp-50 and Lys-84 serve to lower the pKa of this residue and facilitate proton 
donation (Rat 5α-HSD numbering) (8, 28). An early study made systematic conservative 
mutations to the conserved active site residues and discovered that any mutations of 
Tyr-55 were catastrophic to enzyme function (32). Later, a sensitive assay utilizing 
radiolabeled substrates was able to accurately measure the rate enhancement due to the 
conserved catalytic residues and their dependence on pH. Analysis of the rate 
enhancement with the Tyr-55 mutant combined with the observed dependence of kcat on 
pH convincingly demonstrated that Tyr-55 is the catalytic general acid/base. 
Furthermore, mutations of the adjacent residues Lys-84 and His-117 led to pH 
dependent shifts in activity, indicating that these residues play an important role in 
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modifying the pKa of Tyr-55. This was hypothesized to be due to a “push-pull” 
mechanism for proton transfer where His-117 and Lys-84 facilitate proton donation and 
removal, respectively (33). Structural studies with another AKR support the importance 
of Tyr-55 as the general acid/base, but question whether the “push-pull” mechanism is a 
hallmark feature of AKRs. Crystal structures indicate that the longer relative distances 
between Tyr-55, Lys-84, and His-117 in some AKRs are not conducive to proton 
transfer. Instead, it is hypothesized that the ε-NH3+ group of Lys-84 is important for 
electrostatic stabilization while His-117 determines the orientation of the substrate in 
the active site (34) (Figure 1.1). 
Further kinetic analysis with NADP(H) has suggested the rate limiting step for the 
reaction is the isomerization of the enzyme upon binding of the oxidized cofactor and 
before binding of the reduced cofactor (35). Pre-steady state kinetics were performed 
using stopped-flow fluorescence spectroscopy to analyze the change in intrinsic 
fluorescence of the enzyme as it bound the cofactor. The results were consistent with a 
two-step kinetic mechanism: A fast formation of a loose complex (E•NADP(H)), 
followed by a conformation change leading to a tightly bound complex (E*•NADP(H)) 
(36). The associated rates were in good agreement with the kinetic parameters 
calculated from steady state measurements.  
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The cofactor binding pocket is highly conserved amongst AKRs, with most having a 
preference for NADP(H) over NAD(H). As would be expected, the specificity seems to 
be highly dependent on the residues in the cofactor binding pocket that would interact 
with the 2’-phosphate of NADP(H). Attempts to relax the cofactor specificity of 2,5-
diketo-D-gluconic acid (2,5-DKG) reductase from Cornybacterium by making several 
site-directed mutations in this area have identified a number of mutants having 
increased activity with NAD(H) (37). The best single mutant, R238H, exhibited a 7-fold 
improvement in activity with NAD(H), due mostly to an improvement in kcat (38). The 
arginine in the wild type enzyme interacts with the 2’-phosphate of NADP(H) whereas 
the histidine residue in the mutant can form a pi-pi stacking interaction with the 
adenine ring in either cofactor. Kinetic measurements indicated this mutation increased 
the ground state binding affinity for NADH by 0.13 kcal/mol and the binding affinity 
for the transition state by a significant 1.1 kcal/mol (38). 
Other work has indicated that the residues in the nicotinamide pocket also play an 
important role in cofactor specificity (39). Site-directed mutations of residues interacting 
with the nicotinamide ring of NAD(P)(H) suggest different modes of binding of 
NAD(H) compared to NADP(H) in AKRs. The evidence for this is threefold: First, 
mutations in the nicotinamide pocket that affect the affinity for NADP(H) show no 
significant effect on NAD(H) affinity. Second, changes in the Km for NADP+ are much 
greater than those for NAD+, while the catalytic efficiency (kcat/Km) for NAD+ is much 
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more severely impacted. Third, a stopped-flow fluorescence spectroscopy experiment 
showed the isomerization of the enzyme/NADP(H) complex fits a two-state model, 
while the kinetic transient was not observed with NAD(H) (36). An important caveat, 
however, is that all of these experiments were performed with rat liver 3α-HSD, which 
differs from most AKRs at a few highly conserved residues. Thus further investigation 
is required before this altered binding observation can be extended to other members of 
the superfamily. 
 
For this work, we have selected a thermostable AKR from the hyperthermophilic 
archaea Pyrococcus furiosus, alcohol dehydrogenase D (AdhD). This enzyme has several 
features which make it an attractive candidate for protein engineering. The enzyme is 
small (32 kDa), monomeric, and requires no disulfide bonds or metal ions for activity. It 
has been expressed recombinantly in E. coli in high yield, and its extreme 
thermostability (half-life of 130 min at 100°C) allows it to be easily purified in a single 
step (40). Thermostable enzymes have also been shown to have long lifetimes in 
immobilized systems, and are more amenable to mutagenesis than their mesostable 
counterparts. The native preference of AdhD for NAD+ and broad substrate specificity 
provide an ideal starting point for our engineering efforts, and much is known about 
altering cofactor and substrate specificity in this enzyme family.  
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Our first goal was to engineer a simple and general method of immobilizing the scaffold 
enzyme without impacting activity. Previously, we have shown that the fusion of α-
helical leucine zipper domains to the termini of a protein of interest enables self-
assembly into a hydrogel structure. In Chapter 2, we apply this methodology to the 
AdhD scaffold to create a bioactive enzymatic hydrogel. As the enzyme is thermostable, 
we characterize the activity and materials properties of the hydrogel over a range of 
temperatures. Surprisingly, the use of a thermostable protein in this construct was 
found to stabilize the hydrogel structure, and a robust, enzymatically-active hydrogel 
was formed at temperatures exceeding 60°C. 
In Chapter 3, we explore the cofactor specificity of Pyrococcus furiosus AdhD through 
several rational mutations to the cofactor binding pocket. Guided by previous efforts to 
alter cofactor specificity in this family, we were able to identify a double mutant 
enzyme with broadened specificity and significantly improved activity compared to the 
wild-type AdhD. The impact of these mutations on cofactor binding and kinetics is 
characterized using several steady-state and pre-steady state kinetic techniques, and we 
identify a novel cofactor binding mechanism in the engineered double mutant enzyme. 
In Chapter 4, we expand upon the cofactor engineering efforts from Chapter 3 with the 
goal of improving the performance of an immobilized enzyme system. As cofactor 
diffusion is often rate limiting in these architectures, the use of truncated nicotinamide 
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cofactors with improved diffusion rates is investigated. Fortuitously, the previously 
engineered double mutant enzyme is able to utilize the minimal cofactor nicotinamide 
mononucleotide for catalysis. The effect of the minimal cofactor on the turnover rate 
and diffusion are investigated, and an enzymatic biofuel cell for the oxidation of D-
arabinose is constructed with the double mutant enzyme.  
In Chapter 5, we take a rational approach to engineering the substrate specificity of 
AdhD through the modular exchange of AKR substrate binding loops. In order to 
improve the activity of the enzyme with sugars, we grafted in the substrate binding 
loops from human aldose reductase (hAR), which is active with glucose. Replacement 
of at least two substrate binding loops, Loops A and B, was required to impart hAR 
activity into the AdhD scaffold. We also discovered that these mutations were not 
additive with the previously discussed cofactor specificity mutant of AdhD. Grafting 
the same substrate binding loops into the double mutant scaffold, which itself displays 
hAR activity due to its broadened specificity, results in an inactive enzyme. 
The final chapter provides a summary of our efforts toward engineering a general 
dehydrogenase enzymatic scaffold, and discusses preliminary results of a novel 
selection scheme to enable the directed evolution of catalytic activity.  
  
Figures 
Figure 1.1 The active site of 2,5
believed that Tyr50 acts as the catalytic 
the substrate in the active site, and Lys75 forms a salt bridge with Asp45 and is 
responsible for electrostatic stabilization.
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A CHIMERIC FUSION PROTEIN ENGINEERED WITH DISPARATE 
FUNCTIONALITIES — ENZYMATIC ACTIVITY AND SELF ASSEMBLY† 
Abstract: The fusion of protein domains is an important mechanism in molecular 
evolution, and a valuable strategy for protein engineering. We are interested in creating 
fusion proteins containing both globular and structural domains so that the final 
chimeric protein can be utilized to create novel bioactive biomaterials. Interactions 
between fused domains can be desirable in some fusion protein applications, but in this 
case the optimal configuration will enable the bioactivity to be unaffected by the 
structural cross-linking.  To explore this concept, we have created a fusion consisting of 
a thermostable aldo-keto reductase, two α-helical leucine zipper domains, and a 
randomly coiled domain. The resulting protein is bifunctional in that: (1) it can self-
assemble into a hydrogel material as the terminal leucine zipper domains form inter-
protein coiled coil cross-links; and (2) it expresses alcohol dehydrogenase and aldo-keto 
reductase activity native to AdhD from Pyrococcus furiosus. The kinetic parameters of 
the enzyme are minimally affected by the addition of the helical appendages, and 
rheological studies demonstrate that a supramolecular assembly of the bifunctional 
protein building blocks forms a hydrogel. An active hydrogel is produced at 
                                                 
† A version of this chapter is published in The Journal of Molecular Biology (2009), 392, 129-142, with co-
authors Ian Wheeldon and Scott Banta. EC performed experiments and analyzed data (enzyme kinetics 
and CD). 
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temperatures up to 60 °C, and we demonstrate the functionality of the biomaterial by 
monitoring the oxidation and reduction of the native substrates by the gel. The design 
of chimeric fusion proteins with both globular and structural domains is an important 
advancement for the creation of bioactive biomaterials for biotechnology applications 
such as tissue engineering, bioelectrocatalysis, and biosensing and for the study of 
native assembled enzyme structures and clustered enzyme systems such as metabolons.    
 
Introduction 
Molecular evolution relies on diversity in protein structures, and one way this is 
accomplished is through the fusion of native protein domains. There has also been 
much success in the design and engineering of novel chimeric fusion proteins for new 
applications. Examples of globular protein fusions include enzymatic switches (1), light 
activated DNA binders (2), drug and gene delivery systems (3-5) single chain antibodies 
(6), tethered enzymes (7, 8), and many others. There has also been interest in creating 
chimeric structural fusion proteins, such as silk-elastin fusions (9, 10), and leucine 
zipper-elastin fusions (11). We are interested in creating chimeric fusions with both 
globular and structural functionalities such that both domains, and the functions of 
those domains, contribute independently to the final protein construct.   
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Examples of fusion proteins that combine structural functionality and chemical or 
bioactive functionality are relatively uncommon. The literature describes fusions of 
organophosphate hydrolase (12) (OPH) and the protein G Fc binding domain (13) to 
elastin-like peptides for immobilization to hydrophobic surfaces. Also described are 
OPH (14) and horseradish peroxidase (15) fusions to a cellulose binding domain, for 
immoblization on the cellulose surfaces and calmodulin fusions to OPH and β-
lactamase for reversible immobilization on to appropriately modified surfaces (16). 
Perhaps the most common use of protein fusions is in biotechnologies for heterologous 
expression of recombinant proteins and in the purification of such products (17-19).  In 
expression and purification technologies, the fusion is often temporary as cleavage of 
the fusion protein generally occurs en route to the final product. 
We have previously created bifunctional fusion proteins that self-assemble into 
bioactive and enzymatic biomaterials. So far, we have demonstrated the addition of 
structural self-assembly domains to green fluorescent protein (GFP), the tetrameric 
Discosoma red fluorescent protein (DSRed) and a polyphenol oxidase (SLAC) from 
Streptomyces coelicolor (20, 21). The bifunctional proteins are fusions of the globular 
mesostable protein-of-interest (GFP, DSRED and SLAC) and the hydrogel forming 
triblock polypeptide (22), AC10A (here termed HSH). The triblock polypeptide has a 
helix-random coil-helix structure; the terminal α-helical leucine zipper domains form 
tetrameric coiled coils leading to the formation of a supramolecular hydrogel structure. 
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Our bifunctional proteins are fusions of the domains of the triblock polypeptide to the 
termini of the protein-of-interest (or insertions of the protein-of-interest in triblock 
polypeptide). The addition of self-assembly functionality to globular proteins is highly 
useful in that with compatible assembly domains one can produce mixed 
supramolecular structures from more than one type of bifunctional fusion protein (20, 
21). 
In this study, we describe a new bifunctional enzyme that self-assembles to form a 
thermostable, 3-dimensional supramolecular hydrogel that has aldo-keto reductase 
(AKR) activity. This is again accomplished through N- and C-terminal fusions of α-
helical leucine zipper cross-linking domains (22) to the α/β barrel structure of an alcohol 
dehydrogenase with AKR activity, AdhD from Pyrococcus furiosus (23).  The monomers 
are able to self-assemble into a bioactive enzymatic hydrogel that is stable to 
temperatures in excess of 60 °C.   
AdhD is a member of the AKR superfamily that catalyzes the oxidation of secondary 
alcohols under basic conditions (optimum pH 8.8) and reduction of ketones under 
slightly acidic conditions (optimum pH 6.1) with a strong preference towards NAD(H) 
as a cofactor. Activity increases up to 100 °C and AdhD exhibits latent activity towards 
primary alcohols, xylose, glucose, arabinose and glyceraldehydes, among others (23). A 
thermostable bifunctional AdhD is a platform from which one, with additional protein 
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engineering work to modify substrate specificity, could develop mimics to cellular 
metabolic pathways that require co-localization or multi-enzyme complexes (7). The 
complete oxidation of an alcohol to carbon dioxide for electrical power production (24, 
25), and biosensing of transient intermediates within a metabolic pathway are 
applications that would benefit from such a hydrogel system.  
The primary concern is that the addition of a second functionality by genetic fusion will 
eliminate or drastically inhibit the first functionality (21). We show that the fused 
α−helical domains maintain helical secondary structure and that the α/β barrel remains 
highly thermostable. Additionally, we demonstrate that the kinetic parameters 
measured in dilute solution for diol oxidation and ketone reduction are minimally 
affected by the fusions to AdhD. With rheological characterization and erosion studies 
we show supramolecular assemblies of the bifunctional enzyme to be robust and 
thermostable hydrogels. Finally, we demonstrate the functionality of the system as a 
hydrogel made from bifunctional AdhD building blocks can catalyze the oxidation of a 
secondary alcohol and the reduction of a ketone. 
 
Materials and Methods 
Chemicals and Reagents: Mono and dibasic sodium phosphate, glycine, sodium 
chloride, sodium hydroxide, 3-hydroxy-2-butanone, 2,3-butanediol, guanidine HCl, 
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Trizma HCl and Base (TRIS), hydrochloric acid, β-Nicotinamide adenine dinucleotide 
reduced disodium salt (NADH) and β-Nicotinamide adenine dinucleotide (NAD+) were 
purchased from Sigma-Aldrich and used without modification. Isopropyl β-D-1-
thiogalactopyranoside (IPTG; Promega) was also used without modification.  
Ampicillin, kanamycin, spectinomycin, and Terrific Broth media were also purchased 
from Sigma-Aldrich.  Premade sodium dodecyl sulfate polyacrylamide gels for 
electrophoresis (SDS-PAGE) were purchased from Invitrogen.  All protein 
concentrations were determined by Bradford assay with bovine serum albumin 
standards (Pierce). 
Construction of pQE9HSadhH and pQE9HSadh: The plasmid, pWUR85, with adhD 
from Pyrococcus furiosus was a kind gift from John van der Oost (Wageningen 
University, The Netherlands). The expression plasmid and the tRNA helper plasmid, 
pSJS1244, are described in ref(23). The adhD gene was extracted from pWUR85 by 
polymerase chain reaction with forward and reverse primers that include the addition 
of a SphI site both upstream and downstream of the gene (adhD(SphI)-F 
ATATAAGCATGCATGGAATGGCAAAAAGGGTAAATG, the forward primer with 
unique SphI site (underlined) and adhD(SphI)-R, 
AATATAGCATGCCCACACACCTCCTTGCCAT, the reverse primer with unique SphI 
site (underlined)). The resulting fragment was ligated into pQE9AC10Acys (26) (a kind 
gift from David Tirrell, California Institute of Technology) at the unique SphI site 
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between the C10 and Acys domain encoding regions. Successful transformants were 
propagated in 5α Escherichia coli cell line (NEB). The resulting expression plasmid, 
pQE9HSadhH, was also transformed into SG13009 Escherichia coli (Qiagen) harboring 
the repressor plasmid pREP4 and pSJS1244. Successful expression of HS-Adh-H from 
SG13009 cell line requires ampicillin (pQE9HSadhH), kanamycin (pREP4) and 
spectinomycin (pSJS1244). The plasmid encoding HS-Adh was constructed in an 
identical manner as described above with one exception, the adhD gene was extracted 
from pWUR85 with a downstream primer adding a unique SpeI site (adhD(SpeI)-R, 
CGTATAACTAGTTCACACACACCTCCT-TGC with unique SpeI site (underlined)). 
Expression and purification of AdhD, HS-Adh-H and HS-Adh: Expression of AdhD 
followed a  previously described protocol (23). Expression of HS-Adh-H and HS-Adh 
was done in 750 mL batches of Terrific Broth media supplemented with 200 µg mL-1 
ampicillin, 50 µg mL-1 kanamycin and 50 µg mL-1 spectinomycin inoculated with 10 mL 
of mature SG13009 E. coli harboring pQE9HSadhH (or pQE9HSadh), pREP4 and 
pSJS1244. Expression was induced with 0.5 mM of Isopropyl β-D-1-
thiogalactopyranoside upon reaching an OD600 of 0.8-0.9. Expression was allowed to 
continue for 15-16 hours at 27 °C prior to harvesting. Growth prior to induction 
occurred at 37 °C. Cells were harvested by centrifugation at 10,000g for 10 minutes and 
resuspended in 100 mL of 20 mM TRIS pH 7.5 per 750 mL culture.  Cells were lysed by 
heating to 80 °C for 1 hour and clarified by centrifugation for 30 minutes at 10,000g. HS-
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Adh-H (or HS-Adh) was purified from the heat stable lysate by Fast Protein Liquid 
Chromatography (ÄKTA FPLC, GE HealthCare) using a strong anion exchange column 
(Q-FF, GE HealthCare). After injection of the lysate, the column was washed with 20 
mM TRIS pH 7.8 with 200 mM NaCl. The protein of interest was eluted from the 
column with a linear gradient of NaCl in 20 mM TRIS pH 7.8 from 200 mM NaCl to 500 
mM NaCl. Ninety to ninety-five percent pure HS-Adh-H (as judged by SDS-PAGE) 
elutes in a broad peak from 300 mM to 450 mM NaCl. Fractions containing HS-Adh-H 
(or HS-Adh) were pooled and concentrated over a 30 kDa cellulose filter (Millipore) 
while exchanging the buffer to 10 mM dibasic sodium phosphate. The resulting 
concentrated samples of HS-Adh-H and HS-Adh were approximately 95% pure. 
Samples used in kinetic assays and circular dichroism experiments were further 
purified by size exclusion chromatography (SEC; HiLoad 16/20, Superdex 200, GE 
HealthCare) with 20 mM TRIS pH 7.8, 500 mM NaCl. Excess salt was removed from the 
size exclusion eluate by buffer exchange over 30 kDa cellulose filters (Amicon, 
Millipore). The SEC results were compared to low molecular weight calibrations 
standards for size estimation (Gel Filtration LMW Calibration Kit, GE HealthCare). 
Hydrogel formation: Hydrogel samples ranging from 10 to 18 wt% (100-180 mg mL-1) 
were prepared from lyophilized HS-Adh-H (or HS-Adh). Protein was lyophilized from 
anion exchange purified samples after buffer exchange to 10 mM dibasic sodium 
phosphate adjusted with 1 M NaOH to pH 9 and after concentration to 15-25 mg mL-1 
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(approximately 1/10 final hydrogel concentration). Aliquots of the samples were frozen 
to -80 °C and lyophilized to dryness. Hydrogels were formed by re-hydrating the dried 
samples to the desired weight percent and buffer concentration while accounting for the 
initial sample buffer. Hydrogel pH was adjusted by adding 1 M NaOH or 1 M HCl in 
place of equal volumes of water required for re-hydration. Final hydrogel pH was 
measured by fine range pH paper (Whatman and pHydrion).  
Hydrogel Rheology: Small amplitude oscillatory shear experiments were performed 
with a TA Instruments AR 1200 constant stress rheometer equipped with an 8 or 20 mm 
steel parallel plate with a gap of 500 µm, and a constant strain of 1% at 22 – 75 °C 
(Peltier plate temperature control).  A bead of mineral oil around the edge of the sample 
was used to prevent dehydration of the hydrogels during testing. 
Hydrogel Erosion: Hydrogels re-hydrated with 10 µl of aqueous solution were 
prepared in 96 well microtiter plates and covered with 250 µL of 100 mM sodium 
phosphate, pH 7.5.  Percent erosion was determined by monitoring the absorbance at 
280 nm of a sample of open buffer solution over time. 
Circular Dichroism: Experiments were conducted with a Jasco J-815 CD spectrometer 
with Peltier junction temperature control. Five-µM samples of HS-Adh-H (purified by 
SEC) and AdhD in 10 mM sodium phosphate buffer were analyzed in a 1 mm quartz 
cuvette. Solution pH was adjusted with 1 M NaOH and 1 M HCl as required. Spectral 
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deconvolution was accomplished with the CDPro software (27). Each spectrum was 
deconvoluted with each of SELCON3, CONTILL, and CDSSTR, in each case with 4 
protein reference sets. The secondary structure composition is given as an average of 
the 12 deconvolutions with the associated standard deviation. Alpha-helical and β-sheet 
contents are stated as the sum of the ordered and disordered helical and sheet 
deconvolution results.   
Protein denaturation studies: The extent of folding was determined by monitoring the 
circular dichroic absorbance at 222 nm while increasing temperature at a rate of 1 °C per 
minute. Samples were prepared as described for all circular dichroism analysis. Six-
molar guanidine hydrochloride was used in place of phosphate buffer when required. 
Melting temperature, TM, taken as the midpoint parameter of sigmoidal fits to 
temperature scan data at 222 nm. 
Activity assays and determining the steady state kinetic parameters: Oxidative 
activity of AdhD and HS-Adh-H (purified by SEC) was measured with 2,3-butanediol 
and NAD+ cofactor in 50 mM glycine buffer, pH 8.8. Reductive activity was measured 
with 3-hydroxy-2-butanone and NADH cofactor in 100 mM sodium phosphate buffer, 
pH 6.1. The steady state kinetic parameters of the ordered bi bi reaction mechanism, kcat, 




cat NAD(H)[ ] S[ ]
kiNAD( H )KM ,S + KM ,S NAD(H)[ ]+ KM ,NAD( H ) S[ ]+ NAD(H)[ ] S[ ]  (1) 
where S is 2,3-butanediol in the oxidative reaction and 3-hydroxy-2-butanone in the 
reductive reaction. The constant kiNAD(H) was determined by fluorescence titration as 
described below. The initial rates were determined by following the absorbance of 
produced, or consumed, NADH at 340 nm (ε = 6.22 mM-1cm-1) with a SpectraMax M2 
microplate reader (Molecular Devices). Assays were performed in 96-well assay plates 
with an enzyme concentration of 1 – 5 µg mL-1 at 45 °C. Reaction conditions for the 
oxidative reaction were combinations of 5, 10, 25, 50, 100, 250, 500, and 1000 µM NAD+ 
cofactor and 5, 10, 20, 40, 60, 80, and 100 mM 2,3-butanediol. Reaction conditions for the 
reductive reaction were combinations of 1, 5, 10, 25, 50, 100, 175, and 250 µM NADH 
and 0.1, 0.5, 1, 2.5, 5, 10, 20, and 40 mM 3-hydroxy-2-butanone. Each data set was 
repeated in at least quadruplicate. 
The steady state kinetic parameter kiNAD(H) is equivalent to the equilibrium binding 
constant, KD, of the cofactor in the active site of the enzyme (28). A conveniently located 
tryptophan residue at position 92 in the wild type and position 272 in HS-Adh-H allows 
for accurate determination of the binding constant as tryptophan fluorescence is 
quenched upon binding (Ex. 280 nm, Em. 330-340 nm) (29). For both the wild type and 
the bifunctional enzyme, the NAD+ and NADH equilibrium binding constants were 
determined by equation 2.  
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Φ =
kD ,NAD ( H )
−1 NAD(H)[ ]
1+ kD ,NAD( H )
−1 NAD(H)[ ]                (2) 
where Φ is the fraction of NAD(H) bound as determined by fluorescent titration. 
Experiments were done in a 1 cm quartz cuvette with 2 mL of 2 µM enzyme, to which 2 
µL aliquots of concentrated cofactor was added. At each point the fluorescence emission 
at 330 nm for NAD+ titration or at 450 nm for NADH titrations, with excitation at 280 
nm, was recorded. No more than 10 aliquots of concentrated NAD(H) (3, 5 or 10 mM) 
were added during each titration to ensure a negligible change in enzyme 
concentration. At least three titration were performed to determine each of KD,NAD+ and 
KD,NADH for both the wild-type and bifunctional enzyme. Titrations were performed at 
the same conditions as described above for the reduction and oxidation reactions. 
The effect of temperature on enzyme activity was determined by initiating a buffered 
enzyme-substrate solution, equilibrated to the desired temperature, with cofactor. 
Assays were performed in a 1 cm quartz cuvette with a 1.5 mL reaction volume. The 
temperature dependent rate of degradation of NADH was determined from control 
assays without enzyme and subtracted when appropriate. 
All data fits were done using IGOR Pro software with a 95 % confidence interval.  
Statistical significance is reached with p ≤ 0.05 with Student’s t-test. 
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Hydrogel enzymatic activity: Enzymatic activity of hydrogel samples was determined 
by monitoring NADH fluorescence (Ex. 340 nm, Em. 450 nm). Hydrogel samples were 
re-hydrated with buffer containing NAD+ cofactor and reaction was initiated by 
substrate addition. Assays were performed in 384 well black assay plates. Conversion of 
‘in-gel’ NAD+ cofactor to NADH and again to NAD+ was accomplished in 20 µL 
hydrogel of 10 wt% HS-Adh-H rehydrated with 2 mM NAD+ (final volume, wt% and 
concentration after addition of 2,3-butanediol), heated to 45 or 60 °C, and buffered to 
pH 7 with 100 mM sodium phosphate. A 3.8 µL aliquot of 100 mM 2,3-butanediol was 
added at t=0 to initiate the reduction of NAD+ to NADH. Twenty-mM 3-hydroxy-2-
butanone was then added at t=10 minutes to initiate oxidation of ‘in-gel’ NADH. 
Sample pH and concentrations of substrates and cofactor were selected so that the 
equilibriums would favor near complete conversion of the limiting concentration of 




Design, expression and purification of a bifunctional AKR 
Of primary concern in the design of the bifunctional AdhD protein is that the desired 
functions, self-assembly and enzymatic activity, are retained in the final construct and 
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that neither is significantly altered. To aid in the design, a homology model of AdhD 
from Pyrococcus furiosus (accession no. Q8TZM9) was produced in order to evaluate the 
potential impact the bifunctional construct may have on catalytic activity. The 
homology model (Figure 2.1a.) was generated using ESyPred3D and MODELLER (30) 
with primary template prostaglandin F synthase from Trypanosoma brucei (1VBJ, 31.1% 
identities). Structures were analyzed using MolProbity (31) and verified against other 
members of the aldo-keto reductase superfamily.  The conserved residues in the 
catalytic active site of the AKR superfamily (D58, Y63, K89, H121, AdhD numbering) lie 
at the top of the α/β barrel, at the same end but on the opposite side, as the C-terminal 
helix (H2, as per AKR nomenclature (32)). The N-terminus lacks a defined structure, is 
not buried in the α/β barrel structure, and is spatially located at the opposite end of the 
barrel.    
Naïvely, inspection of the homology model suggests that fusions to the N-terminus 
should be innocuous, but that substantial modification to the C-terminus could impair 
catalytic activity. Concern about the latter modification is supported by evidence from 
other authors that have shown that single amino acid mutation to the C-terminus of 
different AKRs can significantly alter catalytic activity (33). We have previously shown 
that the fusions of an α-helical domain (H) and randomly coiled (S) domain in series to 
the N-terminus and a single H-domain to the C-terminus of GFP results in robust 
hydrogel with beneficial properties (20). We hypothesized that the asymmetric order of 
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the domain fusions leads to a reduction in the rate of hydrogel erosion in open buffer 
solution due to the suppression of closed loop formation. Therefore we employ a 
similar fusion strategy in this case. A schematic representation of AdhD with both N- 
and C-terminal modifications is shown in Figure 2.1b. 
AdhD is active to temperatures in excess of 90 °C and has a half-life greater than 2 
hours at 100 °C (23). An enzymatically active, thermostable hydrogel made from self-
assembling HS-Adh-H building blocks requires that physical cross-linking through α-
helical coiled coil formation also occur at elevated temperatures. The structure of the 
appended H-domains, if correctly folded, should confer thermostability to the coiled 
coil bundles to temperatures upwards of 80 °C at pH 6 and to 50 °C at pH 9 (22). 
Optimization of the coiled coil melting temperature at different pH values is possible 
(34); however, the helices used here are amenable to our design goals as they will allow 
for the investigation of both the reductive and oxidation reaction at high temperatures.  
A new bifunctional protein that exhibits AKR activity and self-assembles to form a 
supramolecular hydrogel was produced. A gene encoding the protein, HS-Adh-H, was 
constructed by genetically fusing an H- and S-domain to the N-terminus of AdhD and a 
single H-domain to the C-terminus. The appended H-domains are identical in sequence. 
A control construct, HS-Adh, with only the N-terminal modification was also 
constructed. The full amino acid and genetic sequences of HS-Adh-H, HS-Adh, and 
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AdhD are presented in the supporting information. The H-and S-domains are blocks of 
an engineered tri-block polypeptide, HSH (22, 26). 
The protein constructs were expressed in Escherichia coli and purified by cell lysis at 80 
°C followed by strong anion exchange and size exclusion chromatography (SEC). The 
large amounts of protein required for hydrogel formation prevented extensive use of 
SEC, therefore hydrogel samples were purified by anion exchange purification only. 
The two-step purification resulted in samples of approximately 95% purity and three-
step purification resulted in a slight increase in purity as judged by SDS-PAGE. Yields, 
prior to size exclusion chromatography, of 15 to 25 mg per liter of culture were 
achieved. Protein yields were not substantially reduced after SEC. HS-Adh-H elutes 
from SEC (20 mM TRIS, 500 mM NaCl, pH 7.8) in three broad peaks between protein 
standards of 44,000 and 75,000 kD; however, samples of each fraction appear identical 
with SDS-PAGE analysis. 
Structure and stability of a thermostable α/β barrel with cross-linking appendages 
Circular dichroism (CD) spectroscopy confirms that the H-domains of the bifunctional 
fusion protein HS-Adh-H do form α-helices. The CD spectra of HS-Adh-H and AdhD 
were recorded at intervals of one-half pH units from pH 6 to 9 each at a temperature of 
22, 45, 60 and 90 °C. Spectra of HS-Adh-H and AdhD at pH 6 and 9, at 22 and 90 °C, are 
shown in Figures 2.2a. and b. No aggregation was observed upon heating and cooling 
 35 
of dilute solutions. The spectra suggest that the wild-type AdhD has no perceptible 
structural change with an increase in pH from 6 to 9 and only a small change with an 
increase in temperature from 22 to 90 °C. Conversely, both pH and temperature have an 
effect on the structure of HS-Adh-H.   
Deconvolutions of the spectra support these claims. The α-helical and β-sheet content of 
HS-Adh-H and AdhD at pH 6 (top) and 9 (bottom) at temperature intervals of 22, 45, 60 
and 90 °C are shown in Figure 2.2c. Wild-type AdhD shows a small exchange of α-
helical to β-sheet secondary structure with increasing temperature. The random, or 
unstructured, content remains constant. In comparison to AdhD, the appended HS- and 
H-domains add to the α-helical content of HS-Adh-H at low temperatures, and the total 
β-sheet content is reduced by a similar amount. At 90 °C and pH 6, α-helical content of 
HS-Adh-H drops below that of AdhD (the β-sheet content increases concomitantly). The 
decrease in HS-Adh-H α-helical content occurs at a lower temperature when buffered to 
pH 9, with the percentage helices reaching a value slightly lower than that of AdhD at 
45 °C.  The decrease in α-helical content with increasing temperature at pH 9 is not as 
large as the decrease observed at pH 6, as at 22 °C and pH 9 the α-helical content of HS-
Adh-H is only slightly higher than AdhD.   
The deconvolution and spectral data strongly suggests that the HS- and H-domain 
fusions to the N- and C-terminus of AdhD, respectively, result in the addition of α-
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helical secondary structure and that the α-helical content of HS-Adh-H decreases with 
increasing temperature and increasing pH. The effect that the fusions have on the 
ability of the H-domains to form physical cross-links through coiled coil formation is 
demonstrated in the rheological characterization of concentrated samples presented 
below.  
A concern is that the appended domains will dramatically limit the stability of the 
highly thermostable α/β barrel structure of AdhD. The data presented in Figure 2.3a 
(and Figure 2.2c.) shows that HS-Adh-H undergoes some thermal denaturation at 
temperatures below 90 °C, while wild type AdhD does not. We hypothesize that the 
initial change of HS-Adh-H from the native state is due to the loss of α-helical structure 
of the appended domains and not unfolding of the core of the α/β barrel. This partially 
unfolded structure (denatured helical appendages with an intact, or nearly intact, 
α/β barrel core) forms a stable intermediate prior to complete denaturation. The folded 
state of the α/β barrel core in HS-Adh-H at elevated temperature is supported by 
evidence of enzymatic activity at 90 °C presented below. AdhD in 6 M guanidine 
hydrochloride (GdHCl) buffered to pH 8 denatures with a single unfolding transition 
with a Tm of 76 °C (Figure 2.3b). Without denaturant, HS-Adh-H undergoes a structural 
change with a Tm of 40 °C at pH 8 (Figure 2.3a). With denaturant, HS-Adh-H undergoes 
a second unfolding transition with a Tm of 72 °C (Figure 2.3b). The observed unfolding 
transitions in HS-Adh-H are thermodynamically separated to such a degree that we 
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were unable to identify a denaturant concentration that allows for both transitions to 
occur within a single temperature scan.  The stable α/β barrel core of HS-Adh-H in 
denaturant differ in molar ellipticity per residue in comparison to AdhD (Figure 2.3b) 
as the HS-Adh-H construct contains an additional 261 residues in random or un-
structured conformation in 6 M GdHCl. 
The data presented in Figure 2.3 supports the existence of the hypothesized 
intermediate of HS-Adh-H as unfolding proceeds through two thermally induced 
transitions: the first transition is reversible, and the second is not. Thermodynamic 
analysis of the folded-unfolded transition is not possible as complete unfolding of both 
AdhD and HS-Adh-H in denaturant are irreversible upon cooling. Aggregation of both 
AdhD and HS-Adh-H was observed upon cooling of denaturant solutions but not in 
solutions without denaturant. Comparison of the melting temperatures of AdhD and 
HS-Adh-H in 6 M GdHCl does suggest that the α/β barrel structure of HS-Adh-H is 
slightly destabilized by the appended domains.   
The melting temperatures of the first transient of HS-Adh-H decrease with increasing 
pH (TM > 85 °C at pH 6, 59 °C at pH 7, 40 °C at pH 8, 38 °C at pH 9, see Supplementary 
material Figure 2.8). The TM of the triblock polypeptide HSH is similar to the TM of the 
first unfolding transition of HS-Adh-H at neutral pH and under slightly acidic 
conditions (TM of HSH at pH 6 > 80 °C, and at pH 7 ~55 °C) (22). Under basic conditions, 
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pH 9.5, TM of HSH is approximately 15 °C greater than the TM of HS-Adh-H at pH 9.0.  
Decrease in the stability of the coiled coil domains with increasing pH is expected as the 
negative charge of deprotonated glutamic acid side chains at positions e and g of the 
leucine zipper heptad repeat abcdefg destabilize the structure (35). 
The first functionality: alcohol dehydrogenase and aldo-keto reductase activities 
The N- and C-terminal fusion of HS- and H-domains to AdhD, respectively, do not 
eliminate catalytic activity. In dilute solution assays (specifically, 90 nM or 5x10-4 wt% 
enzyme) and under near saturating concentrations of substrate and cofactor there is no 
significant difference between the oxidative activity of HS-Adh-H and AdhD with 2,3-
butanediol and NAD+ at pH 8.8. Turnover number with 2 mM NAD+ and 100 mM 2,3-
butanediol increases from less than 0.1 s-1 at 25 °C to nearly 40 s-1 at 90 °C (Figure 2.4). 
Under conditions favoring diol oxidation, the CD analysis (presented above) provides 
evidence of thermal denaturation at temperatures above 38 °C. Catalytic activity at 
temperature greater than 45 °C confirms the existence of a stable, partially unfolded 
intermediate. 
A similar trend of increasing activity with increasing temperature is observed in dilute 
solution kinetic assays with ketone reduction. There is no significant difference between 
HS-Adh-H and wild type AdhD turnover number with 250 µM NADH and 100 mM 3-
hydroxy-2-butanone measured at 25, 45 and 60 °C (Figure 2.4). Activity increases from 
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0.1 s-1 at 25 °C to 1.5 s-1 at 60 °C. At 90 °C, reductive activity of HS-Adh-H increases to 12 
± 2 s-1, and to 7 ± 2 s-1 for the unmodified AdhD. The significant difference in reductive 
activities at 90 °C is unexpected as there is no significant difference in activity at all 
other temperatures for both reactions.  
Characteristic to the AKR superfamily is an ordered bi bi reaction mechanism requiring 
the sequential binding of NAD(P)(H) cofactor followed by substrate binding (33, 36, 37). 
Consistent with this mechanism are the trends observed in double reciprocal plots 
(1/activity vs 1/[substrate]) of both AdhD and HS-Adh-H (38). The intersection of linear 
fits to a set of data series of inverse activity as a function of inverse cofactor 
concentration occurs below the x-axis (1/[NAD+]) for the substrate oxidation reaction 
and above the x-axis (1/[NADH]) for the substrate reduction reaction (Figure 2.9).  
The steady state kinetic parameter ki,NAD(H) in the ordered bi bi mechanism (Equation 1, 
Materials and Methods) is equivalent to the equilibrium dissociation constant for the 
cofactors, KD,NAD(H) (28). A conveniently located tryptophan residue in the cofactor 
binding pocket (W92, AdhD numbering) allows for accurate measurement of cofactor 
binding, as tryptophan fluorescence is quenched upon cofactor binding (29). 
Fluorescence titrations reveal a significant difference in dissociation constants, KD,NAD+ 
and KD,NADH, of wild type AdhD and HS-Adh-H. The terminal fusions slightly increase 
affinity for NAD+ (HS-Adh-H, KD,NAD+ = 106 µM; AdhD, KD,NAD+ = 110 µM), while 
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decreasing the affinity towards NADH (HS-Adh-H, KD,NADH = 47 µM; AdhD, KD,NADH = 
38 µM) (Table 2.1). The Michaelis constants KM,NAD+ and KM,NADH also reflect the change 
in cofactor binding, as a statistically significant reduction in KM,NAD+ (HS-Adh-H, 40 µM, 
AdhD, 57 µM) and a statistically significant increase in KM,NADH (HS-Adh-H, 225 µM, 
AdhD, 145 µM) are observed. A significant change in Michaelis constants for the 
substrate (KM,S) is not observed in either the oxidation reaction (HS-Adh-H, 22 mM, 
AdhD, 21 mM) or the reduction reaction (HS-Adh-H 0.24 mM, AdhD, 0.67 mM).    
The change in cofactor binding does not result in a change in maximum rate of kinetic 
turnover, as there is no statistical difference in kcat for either the oxidation reaction (HS-
Adh-H, 3.0 s, -1, AdhD, 2.7 s-1) or reduction reaction (HS-Adh-H, 0.9 s-1, AdhD, 0.8 s-1). It 
is possible that a difference in kcat arises at higher temperatures, as is seen in Figure 2.4. 
Additionally, the steady state kinetic parameters of the ordered bi bi mechanism 
presented in Table 2.1 capture, within experimental error, the turnover number 
measured at near saturating conditions of both reactions for AdhD and HS-Adh-H 
measured at 45 °C (Figure 2.4) (e.g. the predicted turnover number for HS-Adh-H with 
2000 μM NAD+ and 100 mM 2,3-butandiol at pH 8.8 and 45 °C is 2.4 ±1.0, and the 
experimental value was measured to be 1.4 ±0.2 [p = 0.11, n = 5,4]).  The AdhD results 
are consistent with previously published reports (23).  
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The second functionality: supramolecular assembly and hydrogel formation 
At 10 wt%, HS-Adh-H forms a supramolecular hydrogel via physical cross-linking of 
monomers through coiled-coil formation of two or more H-domains (it has previously 
been shown that the H-domains used in this work tend to form tetrameric coiled-coils 
(39)). It is also possible that cross-linking between monomers occurs due to dimer 
formation between the α/β barrel cores as is seen in some AKR family members (40). 
Three separate negative controls, 8 wt% HS-Adh-H, 10 wt% HS-Adh and 20 wt% AdhD 
confirm that two H-domains per monomer are required to form a sufficiently cross-
linked structure, and that a minimum of 10 wt% HS-Adh-H is required to from a stable 
hydrogel structure. Evidence of hydrogel formation, i.e. a shear storage modulus (G′) 
that is greater than the shear loss modulus (G″) over a range of oscillation frequencies 
(41), along with the G′ values of 10 and 14 wt% samples of HS-Adh-H and negative 
controls of 10 wt% HS-Adh and 8 wt% HS-Adh-H are shown in Figure 2.5a. 
A minimum concentration of 10 wt% HS-Adh-H is common to hydrogels at pH 6.3, 7.0, 
8.0 and 9.0 (all hydrogel pH values ±0.2). The shear storage modulus of 10 wt% samples 
of HS-Adh-H at all studied pH values is between 100 and 200 Pa with a loss modulus 
no greater than 50 Pa (Figure 2.5b and Table 2.2). As expected, at low pH (pH < 4) we 
observed protein precipitation and at high pH (pH >12) hydrogel structure is lost due to 
a loss in secondary structure of the appended H-domains (20, 22). 
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Previous works have demonstrated that G′ increases with wt% protein used to make 
the hydrogel material (20, 21, 42). As applications such as enzymatic surface 
modifications and bioelectrocatalysis generally require more rigid hydrogels we 
investigated the temperature dependence of 14 and 18 wt% hydrogels at pH 7 and 9, 
respectively. At 14 wt%, 22 °C and pH 7, HS-Adh-H forms a hydrogel with a G′ of 960 
±140 Pa, a value similar to a previously reported monomeric fluorescence bifunctional 
protein HS-ECFP-H, which attains a G′ value of 1000 Pa at 15 wt%. With additional 
monomers within the structure (18 wt%), G′ increases to 3000 ±540 Pa, 22 °C and pH 9. 
An 18 wt% hydrogel sample at pH 9 demonstrates that the increase in hydrogel 
strength is not limited to neutral pH and that G’ can be increased to at least 3000 kPa. In 
both cases (14 wt%, pH 7 and 18 wt%, pH 9) there is no meaningful change in G′ or G′′ 
up to 60 °C (Figure 2.5c.).  At temperatures above 60 °C, G′ decreases and G″ increases, 
but a hydrogel persists (as G′ > G′′) to the end of the temperature ramp at 75 °C. Ten-
wt% samples of HS-Adh-H also persist at high temperatures. At pH 6.3, 7.0, 8.0, and 9.0, 
10 wt% samples of HS-Adh-H maintain hydrogel characteristics at temperatures up to 
65 °C (Figure 2.5c and Figure 2.10). 
The coiled coil tertiary structure is transient in that strand exchange occurs between 
coiled coils (26, 43). That is to say that an individual H-domain within a coiled coil can 
exchange places with another H-domain of a different coiled coil. Strand exchange 
results in a small number of monomers forming a separate unit (closed loop) that is not 
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attached to the larger hydrogel structure. Surface erosion, the loss of protein multimers 
(or monomers) from the surface of the hydrogel, occurs when closed loops at the 
surface of the hydrogel diffuse away into open buffer solution. We have previously 
shown that the asymmetrical structures of HS-GFP-H and HS-DSRED result in 
suppression of closed loop formation leading to an increase in hydrogel longevity (20). 
Erosion rate can also be suppressed by creating a mismatch of aggregation number 
between N- and C-terminal H-domains (43). We have also shown that covalent cross-
linking after hydrogel formation results in a near complete suppression of erosion (21).   
As expected, HS-Adh-H does erode in quiescent buffer solution (Figure 2.6).  At 25 °C 
and pH 7, a 12 wt% (2.2 mM) HS-Adh-H hydrogel erodes at a rate of 120 ±10 pmol min-
1cm-2 (a 10 µL gel is nearly 30% eroded after 2.5 hrs), a value comparable to that of HS-
GFP-H (18 wt% or 3.4 mM, 93 pmol min-1cm-2) (20). Under similar conditions a 7.5 wt% 
(3.4 mM) sample of triblock polypeptide, HSH, readily forms closed loops and 
completely erodes within 150 minutes (43). At 45 °C, the erosion rate of HS-Adh-H 
increases to 390 ±30 pmol min-1cm-2, likely due to an increase in the rate of strand 
exchange at the elevated temperature. 
Hydrogel formation does not prevent enzymatic activity. In Figure 2.7 we demonstrate 
the bifunctionality of HS-Adh-H: enzymatic reaction within a self-assembled hydrogel 
of HS-Adh-H building blocks. In hydrogel samples re-hydrated with buffer containing 
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NAD+ cofactor we monitor the production and consumption of NADH by fluorescence 
detection upon initiating the oxidative and reductive reactions at 45 °C with 2,3-
butanediol and 3-hydroxy-2-butanone, respectively. After the addition of the substrate 
solutions the final HS-Adh-H concentration was 10 wt%, a concentration sufficient to 
form a hydrogel structure. Importantly, we observe that liquid solutions added to HS-
Adh-H hydrogel samples are rapidly absorbed into the hydrogel. Reaction and 
hydrogel conditions were optimized so that we could observe a second change in the 
redox state of ‘in-gel’ cofactor while moving towards a new equilibrium point after 
addition of 3-hydroxy-2-butanone. An optimized set of conditions were found at pH 7 
were the reaction rate of the oxidation reaction is sub-optimial (23). 
Upon addition of 3.8 µL of 100 mM 2,3-butanediol to a 14.2 µL sample of HS-Adh-H 
containing NAD+, the reaction proceeds towards an equilibrium state favoring NADH 
due to the limiting concentration of cofactor and high enzyme loading (Figure 2.7a). 
Upon addition of 2 µL of 20 mM 3-hydroxy-2-butanone, the reduction reaction proceeds 
towards an equilibrium that favors NAD+ and diol. Enzymatic activity is due to HS-
Adh-H monomers that are incorporated within the hydrogel as there is no open buffer 
solution at the surface of the hydrogel for erosion to occur. The reaction rate during the 
first minute after addition of oxidation of 2,3-butanediol in figure 2.7a is greater than 
the reaction rate due to eroded monomers alone, if erosion had been able to occur 
during that time (Figure 2.11).    
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Similar reaction profiles with the initiation of the oxidation and reduction reactions are 
observed at 60 °C (Figure 2.12). Additionally, control of the redox state of ‘in-gel’ 
cofactor is possible through changes in hydrogel pH (Figure 2.7b). A basic shift from 
slightly acidic to basic conditions induces the concomitant oxidation of 2,3-butanediol 




Here we demonstrate that a fusion protein of α-helical leucine zipper domains to the 
termini of the thermostable AdhD from Pyrococcus furiosus results in a bifunctional 
protein building block that self-assembles into a thermostable enzymatic hydrogel. The 
bifunctional protein building block, HS-Adh-H, expresses the disparate functions of its 
constituent parts. The α/β core of AdhD is catalytically active and the α-helical leucine 
zipper domains form coiled coil cross-links in a supramolecular hydrogel structure.  
In contrast to some members of the AKR superfamily (33, 36), mutation to the C-
terminus of AdhD, specifically addition to the C-terminus, does not dramatically affect 
substrate binding or catalytic functionality. The N- and C-terminal fusions to AdhD do 
alter cofactor binding, but in such a way as to not inhibit turnover under saturating 
conditions.  AdhD lacks substrate binding loops common among some members of the 
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AKR superfamily, and one or more of these loops is often at the C-terminus (36) (Figure 
2.13). The relatively benign nature of the C-terminal fusion to AdhD in HS-Adh-H is 
evidence for the lack of importance of the C-terminal domain in substrate binding and 
enzymatic activity of AdhD. The terminal fusions to AdhD from Pyrococcus furiosus do 
not eliminate enzymatic activity. In fact, catalytic turnover at saturating conditions is 
unaffected.  Cofactor binding is affected, but modification to the C-terminus results in a 
less than one fold difference in kcat/KM,NAD+ for the oxidation of 2,3-butanediol (AdhD, 50 
s-1mM-1, HS-Adh-H, 75 s-1mM-1 ) and kcat/KM,NADH for the reduction of 3-hydroxy-2-
butanone is remains relatively unchanged (AdhD, 6 s-1 mM-1, HS-Adh-H, 4 s-1 mM-1). 
The minimal disruption of AdhD enzymatic activity in the HS-Adh-H fusion is 
noteworthy as it is not always the case that fusions are benign. A bifunctional protein of 
similar design to HS-Adh-H, HS-SLAC (SLAC is a dimeric polyphenol oxidase) results 
in more than two orders of magnitude decrease in kcat/KM (21). Conversely, fusion of an 
elastin-like peptide domain to organphosphate hydrolase (OPH) results in only a 16% 
decrease in kcat/KM (12). OPH activity is minimally affect in a cellulose binding domain 
fusion (CBD) (14), but enzymatic activity is decreased by one order of magnitude in a 
calmodulin-OPH fusion (16). Additionally, there is no measurable difference in 
horseradish peroxidase (HRP) activity between the wild-type and a CBD-HRP fusion 
(15). Cross-comparison of the different fusions does not provide specific insight into the 
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different protein engineering problems, but does highlight the success of the HS-Adh-H 
fusion and leads to the simple observation that each case is unique. 
The demonstration of enzymatic activity within a hydrogel sample of HS-Adh-H 
presented in Figure 2.7 does not provide data for evaluation of the specific activity of 
active sites within the hydrogel construct. It is possible that immobilization AdhD 
within the supramolecular structure results in a decrease in enzymatic capacity either 
through structural change to the active site or due to substrate and cofactor diffusion 
limitations within the hydrogel. The enzymatic activity shown in Figures 2.7 and 2.12 is 
due to monomers that are crosslinked within the hydrogel as there is no open buffer 
solution for erosion to occur as added substrate solution is quickly absorbed into the 
hydrogel and a hydrogel structure is maintain throughout the course of the experiment. 
It should also be noted that in the experiments where reversibility is demonstrated 
(Figure 2.7a, Figure 2.12), the reactions were performed at pH 7.0 which is not optimal 
for either the oxidative or reductive reactions, and therefore the kinetics of the enzymes 
will be slower than what is reported in Table 2.1 at the more optimal pH values. 
Circular dichroism analysis suggests that HS-Adh-H passes through an enzymatically 
active but partially unfolded intermediate in which the appended helical domains 
change conformation while the AdhD α/β barrel core remains intact. The pH dependent 
TM of the first unfolding transition is greater than 85 °C at pH 6 and decreases to 38 °C 
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at pH 9.  The destabilization of the coiled-coil structure with increasing pH is due to the 
increase in negative charge with progressive deprotonation of glutamic acid residues at 
positions e and g (35). The apparent decrease in stability of the H-domains of HS-Adh-H 
with respect to HSH could possibly be a result of some interference of helical coil 
formation by the AdhD protein core. Since there is no linker region on the C-terminal 
side, it is possible that this H-domain is sterically inhibited from complete formation of 
coiled coils. 
A second thermal unfolding transition in HS-Adh-H is observed with 6 M GdHCl at a 
TM 4 °C less than the single thermal unfolding transition of AdhD in 6 M GdHCl (Figure 
2.3b).  The two state unfolding of HS-Adh-H is confirmed by the catalytic activity of the 
HS-Adh-H fusion at pH 6.1 and 8.8 at 90 °C (Figure 2.4). The minimal difference in 
kinetic parameters of HS-Adh-H with respect to the wild type enzyme and the 
measurement of enzymatic activity at temperatures above the first unfolding transition 
imply that the α/β barrel core of HS-Adh-H remains folded and the observed unfolding 
transition at low temperature is the loss or change of structure of the appended helical 
domains. Combined the CD analysis and dilute solution kinetic assays demonstrate two 
aspects of the structure of HS-Adh-H: 1) the terminal fusions add α-helical structure to 
the protein independent of the α/β barrel core; and 2) the fusions do not substantially 
reduce the highly thermostable nature of the AdhD core.  
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Secondary structure analysis of the CD measurements suggests that at pH > 7 α-helical 
formation, and consequently hydrogel formation, is limited to temperatures of 
approximately 40 °C. At pH 8 and 9, 10 wt% samples of HS-Adh-H at pH from 6.3 to 9.0 
are stable to temperatures up to 65 °C (Figure 2.5c, Figure 2.12 and Table 2.2). The TM of 
the H-domains at pH 8 and 9, as determined under dilute solution conditions required 
for the CD analysis, are 40 °C and 38 °C respectively. It is likely that α-helical secondary 
structure is concentration dependent and is stabilized by the formation of coiled coil 
bundles; consequently, hydrogel stability (through physical cross-linking between 
monomers by coiled-coil formation and potentially by protein-protein interactions) is 
limited not to the temperature dependence observed in the dilute solution experiments. 
The TM data does not predict the temperature-dependent behavior of the secondary 
structure of HS-Adh-H samples at hydrogel forming concentrations (i.e. concentrations 
that are more than three orders of magnitude higher than the CD analysis). The 
discrepancy in thermal stability of the α-helical secondary structure in dilute solution 
and HS-Adh-H hydrogels is also observed at neutral pH. 
Five-wt% samples of HSH (22) and 10 wt% samples of a triblock polypeptide with HSH 
structure but with different H-domain sequences (44) show an increase in liquid-like 
character as temperature is increased from 23 to 55 °C; however, direct comparison of 
an HS-Adh-H supramolecular structure to one of HSH is inappropriate as the structures 
are distinctly different. In the case presented here, the C-terminal cross-links are 
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immobilized by a thermostable α/β barrel potentially adding to the stability of the motif. 
Additionally, an increase in cross-linking density could results from specific and non-
specific protein-protein interactions between α/β cores and suppression of closed loop 
formation increases connectivity of the network. While the differences in systems are 
substantial, a comparison of the two systems reveals that the inclusion of the AdhD 
protein with the supramolecular structure has significant implications on the 
mechanisms of connectivity within the hydrogel. 
The N-terminal fusion of a randomly coiled domain is included in the design as it is 
highly soluble (22) and it allows for physical separation between protein cores within 
the hydrogel. It has been shown that it is not essential to hydrogel formation (45) 
provided that the construct is sufficiently soluble.  Also, we envision control over 
hydrogel porosity by controlling the length and placement of the S-domain. 
 
Conclusions 
The chimeric fusion protein, HS-Adh-H, self-assembles to form a thermostable 
enzymatic hydrogel. The protein is bifunctional in that it forms the physical structure of 
a hydrogel while retaining the enzymatic activity of the enzyme. The appended α-
helical leucine zipper domains are responsible for the formation of a physically cross-
linked hydrogel at a minimum concentration of 10 wt% protein. The N- and C-terminal 
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fusions to AdhD minimally affect native enzymatic activity.  Enzymatic activity of the 
bifunctional protein increases with temperature, and hydrogel formation is lost at high 
temperatures; we produce a rigid hydrogel with enzymatic activity at 60 °C. Our design 
will have use in a broad range of biotechnology applications such as enzymatic 
hydrogels for heterogeneous catalysis, electrode modifications for bioelectrocatalysis, 
enzymatically active surface coatings for biosensors, tissue engineering scaffolds, and 
the development of artificial metabolons. We also present it as an example of a general 
design for functional and multifunctional hydrogels. 
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Tables and Figures 
 
  kcat KM,S KM,NAD(H) KD,NAD(H) 




HS-Adh-H 3.0 ±0.7 22 ±2.4 40 ±6.2* 106 ±1.8* 




HS-Adh-H 0.9  ±0.2 0.24 ±0.04 225  ±35* 47  ±2* 
AdhD 0.8  ±0.2 0.67 ±0.13 145  ±26* 38  ±1* 
 
Table 2.1 Kinetic constants for HS-Adh-H and wild type AdhD for the oxidation of 2,3-
butanediol at pH 8.8 and 45 °C and the reduction of 3-hydroxy-2-butanone at pH 6.1 
and 45 °C. Statistically significant difference indicated by * (p<0.05). 
  
Figure 2.1  Structure of AdhD and bifunctional HS
homology model of AdhD from 
active site residue side chains shown.  C
the page.  N-terminus is at the bottom of the 
HS-Adh-H. AdhD with α-helical (H) and randomly coiled (S) domains fused to the N
terminus and an α-helical (H) domain fused to the C




-Adh-H.  a. Top view of the 
Pyrococcus furiosus with N- and C-termini indicated and 
-terminus is at the top of the α/β
α/β barrel, into the page. 
-terminus.  Part
ce is provided in the Supplemental Information
 
 barrel, out of 




Figure 2.2 Circular dichroism (CD) analysis of HS
a. CD spectra in molar ellipticity per residue of 5 
buffer.  b. CD spectra of AdhD, conditions same as a.  
determined by spectral deconvolution, of spectra of HS





-Adh-H and wild type AdhD.  
µM HS-Adh-H, 10 mM phosp
c. α-helix and β






Figure 2.3 Thermal denaturing of H
222 nm, [φ]222, of HS-Adh-H (solid lines) and AdhD (dots) from 25 to 90 






S-Adh-H and AdhD.  Molar ellipticity per residue at 
 
°C.  Samples 
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Figure 2.4 Turnover number of AdhD (grey) and HS-Adh-H (black) with saturating 
substrate concentrations at 25, 45, 60 and 90 °C. Oxidation of 100 mM 2,3-butanediol 
(top) with 2000 µM NAD+, buffered to pH 8.8 with 100 mM sodium phosphate. 
Reduction of 100 mM 3-hydroxy-2-butanone (bottom) with 250 µM NADH, buffered to 
pH 6.1 with 100 mM sodium phosphate. Statistically significant difference indicated by 
* (p<0.05). Error bars are standard deviations.  
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Figure 2.5  HS-Adh-H hydrogel rheology.   
(a) Storage modulus, G′, of 8 wt% HS-Adh-H 
and 10 wt% HS-Adh negative controls and 10 
and 14 wt% HS-Adh-H hydrogels at 22 °C, pH 
7.  Small amplitude oscillatory shear 
frequency sweeps depicting G′ (filled) and G′′ 
(open) of each sample is depicted as an inset 
above each data bar.  
(b) G′ and G′′ of 10 wt% samples of HS-Adh-H 
at pH 6, 7, 8 and 9. All pH values ±0.2.  
(c) Temperature dependence of 10, 14 and 18 
wt% HS-Adh-H hydrogels: 10 and 14 wt% 
data presented for hydrogels at pH 7, 18 wt% 
data taken a pH 9. G′ of each wt% sample at 
22, 45, 60 and 65 °C are bars and temperature 
scans of G′ (filled) and G″ (open) for 14 and 18 





Figure 2.6 Fraction eroded of a 12 wt% (2.2 mM) hydrogel of HS-Adh-H, pH 7, 25 °C 
(closed) and 45 °C (open circles).  Ten-µL hydrogel samples in 25X quiescent buffer 




Figure 2.7 Enzymatic hydrogel activity.  
(a) Conversion of in-gel NAD+ to NADH by 
initiating the oxidation of 2,3-butanediol and 
the conversion of produced NADH to NAD+ 
by initiating the reduction of 3-hydroxy-2-
butanone at pH 7, 45 °C in a 10 wt% hydrogel 
of HS-Adh-H (final wt% after the additions of 
2,3-butanediol at t=0 and 3-hydroxy-2-
butanone at t=8 minutes). Hydrogel re-
hydrated with 2 mM NAD+ (final 
concentration). Reduction of NAD+ to NADH 
initiated with 21 mM 2,3-butanediol (diol). 
Perturbation to a new equilibrium initiated 
with 20 mM 3-hydroxy-2-butanone (ketone). 
(b.) Initiation of the oxidation of 2,3 
butanediol and the conversion of in-gel NAD+ 
to NADH by a basic shift in pH. Times of 






AdhD, HS-Adh and HS-Adh-H amino acid sequences. 
 
AdhD 
MAKRVNAFND LKRIGDDKVT AIGMGTWGIG GRETPDYSRD KESIEAIRYG LELGMNLIDT  60   
AEFYGAGHAE EIVGEAIKEF EREDIFIVSK VWPTHFGYEE AKKAARASAK RLGTYIDLYL  120  
LHWPVDDFKK IEETLHALED LVDEGVIRYI GVSNFNLELL QRSQEVMRKY EIVANQVKYS  180  
VKDRWPETTG LLDYMKREGI ALMAYTPLEK GTLARNECLA KIGEKYGKTA AQVALNYLIW  240  




MRGSHHHHHH GSDDDDKWAS GDLENEVAQL EREVRSLEDE AAELEQKVSR LKNEIEDLKA  60   
EIGDHVAPRD TSYRDPMGAG AGAGPEGAGA GAGPEGAGAG AGPEGAGAGA GPEGAGAGAG  120  
PEGAGAGAGP EGAGAGAGPE GAGAGAGPEG AGAGAGPEGA GAGAGPEGAR MHGMAKRVNA  180  
FNDLKRIGDD KVTAIGMGTW GIGGRETPDY SRDKESIEAI RYGLELGMNL IDTAEFYGAG  240  
HAEEIVGEAI KEFEREDIFI VSKVWPTHFG YEEAKKAARA SAKRLGTYID LYLLHWPVDD  300  
FKKIEETLHA LEDLVDEGVI RYIGVSNFNL ELLQRSQEVM RKYEIVANQV KYSVKDRWPE  360  
TTGLLDYMKR EGIALMAYTP LEKGTLARNE CLAKIGEKYG KTAAQVALNY LIWEENVVAI  420  
PKASNKEHLK ENFGAMGWRL SEEDREMARR CV                                452 
 
HS-Adh-H 
MRGSHHHHHH GSDDDDKWAS GDLENEVAQL EREVRSLEDE AAELEQKVSR LKNEIEDLKA  60   
EIGDHVAPRD TSYRDPMGAG AGAGPEGAGA GAGPEGAGAG AGPEGAGAGA GPEGAGAGAG  120  
PEGAGAGAGP EGAGAGAGPE GAGAGAGPEG AGAGAGPEGA GAGAGPEGAR MPHGMAKRVN  180  
AFNDLKRIGD DKVTAIGMGT WGIGGRETPD YSRDKESIEA IRYGLELGMN LIDTAEFYGA  240  
GHAEEIVGEA IKEFEREDIF IVSKVWPTHF GYEEAKKAAR ASAKRLGTYI DLYLLHWPVD  300  
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DFKKIEETLH ALEDLVDEGV IRYIGVSNFN LELLQRSQEV MRKYEIVANQ VKYSVKDRWP  360  
ETTGLLDYMK REGIALMAYT PLEKGTLARN ECLAKIGEKY GKTAAQVALN YLIWEENVVA  420  
IPKASNKEHL KENFGAMGWR LSEEDREMAR RCVGMPTSGD LENEVAQLER EVRSLEDEAA  480  
ELEQKVSRLK NEIEDLKAEI GDHVAPRDTS MGGC                              514 
 
DNA sequences of AdhD, HS-Adh and HS-Adh-H 
 
AdhD 
ATGGCAAAAA GGGTAAATGC ATTCAACGAC CTTAAGCGTA TAGGAGATGA TAAGGTAACG 60 
GCAATTGGAA TGGGAACATG GGGAATAGGA GGGAGAGAGA CCCCAGACTA TTCTAGGGAT 120 
AAGGAAAGCA TAGAAGCAAT AAGATATGGA CTTGAATTAG GAATGAATTT AATCGACACA 180 
GCGGAATTCT ATGGAGCTGG TCATGCTGAG GAAATAGTTG GAGAGGCCAT TAAAGAATTC 240 
GAACGTGAGG ACATCTTCAT AGTGAGCAAG GTCTGGCCAA CTCACTTTGG GTATGAGGAA 300 
GCAAAGAAGG CTGCTAGAGC AAGTGCTAAA AGGTTAGGAA CTTATATTGA CCTTTATTTG 360 
TTGCACTGGC CCGTTGATGA CTTCAAGAAG ATAGAGGAGA CACTTCACGC TTTGGAAGAC 420 
CTCGTAGATG AGGGAGTGAT AAGGTACATT GGAGTTAGCA ACTTCAATCT GGAACTTCTC 480 
CAGCGCTCCC AGGAGGTCAT GAGGAAGTAT GAGATTGTAG CAAATCAAGT TAAATACTCA 540 
GTGAAAGACC GCTGGCCCGA AACTACAGGA CTTCTCGACT ACATGAAGCG TGAAGGAATA 600 
GCATTAATGG CGTACACACC TCTAGAAAAG GGAACTCTTG CAAGGAATGA ATGTCTAGCT 660 
AAAATTGGAG AAAAATACGG AAAAACAGCT GCTCAAGTGG CTTTAAACTA CCTGATTTGG 720 
GAGGAAAATG TTGTAGCAAT TCCAAAAGCA AGCAACAAGG AACACCTCAA AGAAAACTTT 780 
GGAGCTATGG GATGGAGGCT TTCAGAGGAG GATAGAGAGA TGGCAAGGAG GTGTGTGTGA 840 
 
HS-Adh 
ATGACGATGA CAAATGGGCT AGCGGTGACC TGGAAAACGA AGTGGCCCAG CTGGAAAGGG 60 
AAGTTAGATC TCTGGAAGAT GAAGCGGCTG AACTGGAACA AAAAGTCTCG AGACTGAAAA 120 
ATGAAATCGA AGACCTGAAA GCCGAAATTG GTGACCATGT GGCGCCTCGA GACACTAGCT 180 
ATCGCGATCC GATGGGTGCC GGCGCTGGTG CGGGCCCGGA AGGTGCAGGC GCTGGTGCGG 240 
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GCCCGGAAGG TGCCGGCGCT GGTGCGGGCC CGGAAGGTGC AGGCGCTGGT GCGGGCCCGG 300 
AAGGTGCCGG CGCTGGTGCG GGCCCGGAAG GTGCAGGCGC TGGTGCGGGC CCGGAAGGTG 360 
CCGGCGCTGG TGCGGGCCCG GAAGGTGCAG GCGCTGGTGC GGGCCCGGAA GGTGCCGGCG 420 
CTGGTGCGGG CCCGGAAGGT GCAGGCGCTG GTGCGGGCCC GGAAGGTGCC CGCATGCATG 480 
GCAAAAAGGG TAAATGCATT CAACGACCTT AAGCGTATAG GAGATGATAA GGTAACGGCA 540 
ATTGGAATGG GAACATGGGG AATAGGAGGG AGAGAGACCC CAGACTATTC TAGGGATAAG 600 
GAAAGCATAG AAGCAATAAG ATATGGACTT GAATTAGGAA TGAATTTAAT CGACACAGCG 660 
GAATTCTATG GAGCTGGTCA TGCTGAGGAA ATAGTTGGAG AGGCCATTAA AGAATTCGAA 720 
CGTGAGGACA TCTTCATAGT GAGCAAGGTC TGGCCAACTC ACTTTGGGTA TGAGGAAGCA 780 
AAGAAGGCTG CTAGAGCAAG TGCTAAAAGG TTAGGAACTT ATATTGACCT TTATTTGTTG 840 
CACTGGCCCG TTGATGACTT CAAGAAGATA GAGGAGACAC TTCACGCTTT GGAAGACCTC 900 
GTAGATGAGG GAGTGATAAG GTACATTGGA GTTAGCAACT TCAATCTGGA ACTTCTCCAG 960 
CGCTCCCAGG AGGTCATGAG GAAGTATGAG ATTGTAGCAA ATCAAGTTAA ATACTCAGTG 1020 
AAAGACCGCT GGCCCGAAAC TACAGGACTT CTCGACTACA TGAAGCGTGA AGGAATAGCA 1080 
TTAATGGCGT ACACACCTCT AGAAAAGGGA ACTCTTGCAA GGAATGAATG TCTAGCTAAA 1140 
ATTGGAGAAA AATACGGAAA AACAGCTGCT CAAGTGGCTT TAAACTACCT GATTTGGGAG 1200 
GAAAATGTTG TAGCAATTCC AAAAGCAAGC AACAAGGAAC ACCTCAAAGA AAACTTTGGA 1260 
GCTATGGGAT GGAGGCTTTC AGAGGAGGAT AGAGAGATGG CAAGGAGGTG TGTGTGA 
 
HS-Adh-H 
ATGAGAGGAT CGCATCACCA TCACCATCAC GGATCCGATG ACGATGACAA ATGGGCTAGC 60 
GGTGACCTGG AAAACGAAGT GGCCCAGCTG GAAAGGGAAG TTAGATCTCT GGAAGATGAA 120 
GCGGCTGAAC TGGAACAAAA AGTCTCGAGA CTGAAAAATG AAATCGAAGA CCTGAAAGCC 180 
GAAATTGGTG ACCATGTGGC GCCTCGAGAC ACTAGCTATC GCGATCCGAT GGGTGCCGGC 240 
GCTGGTGCGG GCCCGGAAGG TGCAGGCGCT GGTGCGGGCC CGGAAGGTGC CGGCGCTGGT 300 
GCGGGCCCGG AAGGTGCAGG CGCTGGTGCG GGCCCGGAAG GTGCCGGCGC TGGTGCGGGC 360 
CCGGAAGGTG CAGGCGCTGG TGCGGGCCCG GAAGGTGCCG GCGCTGGTGC GGGCCCGGAA 420 
GGTGCAGGCG CTGGTGCGGG CCCGGAAGGT GCCGGCGCTG GTGCGGGCCC GGAAGGTGCA 480 
GGCGCTGGTG CGGGCCCGGA AGGTGCCCGC ATGCCGCATG GAATGGCAAA AAGGGTAAAT 540 
GCATTCAACG ACCTTAAGCG TATAGGAGAT GATAAGGTAA CGGCAATTGG AATGGGAACA 600 
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TGGGGAATAG GAGGGAGAGA GACCCCAGAC TATTCTAGGG ATAAGGAAAG CATAGAAGCA 660 
ATAAGATATG GACTTGAATT AGGAATGAAT TTAATCGACA CAGCGGAATT CTATGGAGCT 720 
GGTCATGCTG AGGAAATAGT TGGAGAGGCC ATTAAAGAAT TCGAACGTGA GGACATCTTC 780 
ATAGTGAGCA AGGTCTGGCC AACTCACTTT GGGTATGAGG AAGCAAAGAA GGCTGCTAGA 840 
GCAAGTGCTA AAAGGTTAGG AACTTATATT GACCTTTATT TGTTGCACTG GCCCGTTGAT 900 
GACTTCAAGA AGATAGAGGA GACACTTCAC GCTTTGGAAG ACCTCGTAGA TGAGGGAGTG 960 
ATAAGGTACA TTGGAGTTAG CAACTTCAAT CTGGAACTTC TCCAGCGCTC CCAGGAGGTC 1020 
ATGAGGAAGT ATGAGATTGT AGCAAATCAA GTTAAATACT CAGTGAAAGA CCGCTGGCCC 1080 
GAAACTACAG GACTTCTCGA CTACATGAAG CGTGAAGGAA TAGCATTAAT GGCGTACACA 1140 
CCTCTAGAAA AGGGAACTCT TGCAAGGAAT GAATGTCTAG CTAAAATTGG AGAAAAATAC 1200 
GGAAAAACAG CTGCTCAAGT GGCTTTAAAC TACCTGATTT GGGAGGAAAA TGTTGTAGCA 1260 
ATTCCAAAAG CAAGCAACAA GGAACACCTC AAAGAAAACT TTGGAGCTAT GGGATGGAGG 1320 
CTTTCAGAGG AGGATAGAGA GATGGCAAGG AGGTGTGTGG GCATGCCGAC TAGCGGTGAC 1380 
CTGGAAAACG AAGTGGCCCA GCTGGAAAGG GAAGTTAGAT CTCTGGAAGA TGAAGCGGCT 1440 
GAACTGGAAC AAAAAGTCTC CAGACTGAAA AATGAAATCG AAGACCTGAA AGCCGAAATT 1500 
GGTGACCATG TGGCGCCTCG AGACACTAGT ATGGGTGGCT GCTAGGATCC GTCGACCTGC 1560 
AGCCAAGCTT AATTAGCTGA GCTTGGACTC CTGTTGATAG ATCCAGTAAT GACCTCAGAA 1620 






Figure 2.8 Molar ellipticity per residue, [θ], of HS-Adh-H at 222 nm, temperature ramp 
of 1 °C min-1 for samples buffered to pH 6(black), 6.5(light blue), 7(yellow), 7.5(red), 
8(green), 8.5(purple) and 9(dark blue). Scans of 5 µM samples in 10 mM sodium 
phosphate buffer, pH adjusted with 1 M NaOH or 1 M HCl as required. Melting 
temperature, TM, taken as midpoint of the sigmoidal fits to the temperature scan data at 
222 nm (solid lines). 
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Figure 2.9 Lineweaver-Burk plots. Inverse specific activity towards the oxidation of 2,3-
butanediol with NAD+ cofactor, buffered to pH 8.8 with 50 mM glycine at 45 °C for HS-
Adh-H (a) and AdhD (b). Inverse specific activity towards the reduction of 3-hydroxy-
2-butanone with NADH cofactor, buffered to pH 6.1 with 100 mM NaiP at 45 °C for HS-







Figure 2.10 Small amplitude oscillatory shear of 10 wt% samples of HS-Adh-H at pH 7, 
45 °C(left), and 60 °C (right). Data taken with a 20 mm steel parallel plate, 500 µm gap, 




Table 2.2 Storage and loss modulus of HS-Adh-H at high temperature. Experimental 
conditions: 20 mm steel parallel plate, 500 µm gap, 1% strain, 10 rad s-1, temperature 
ramp from 25 to 75 °C, 0.5 °C per minute. 
  
HS-Adh-H wt% pH (± 0.2) G' ; G"  (Pa) at 
65 °C
10 6.3 30 ; 10
10 7.0 110 ; 25
10 8.0 150 ; 30




Figure 2.11 Experimental and model ‘in gel’ activity with HS-Adh-H hydrogels. The 
first two minutes of the data presented in Figure 2.7a is presented here as open circles. 
The reaction profile predicted from the kinetic parameters of the oxidation reaction at 
pH 8.8 and 45 °C for a solution of HS-Adh-H equal to the hydrogel forming 
concentration of HS-Adh-H and substrate and cofactor concentrations as presented in 
Figure 2.7a is plotted as black squares. The apparent decrease in activity from the 
predicted reaction profile to the experimental reaction profile can be explained by 
several reasons. The kinetic parameters were measured at pH 8.8 while the hydrogel 
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experiments were performed at pH 7.0 where the enzyme does not exhibit maximal 
activity. Also, in the gel state there will be significant effects due to diffusion of 
substrates and cofactors within the hydrogel structure.  And it is also possible that a 
decrease in activity of HS-Adh-H occurs as a result of structural changes due to cross-
linking that were not observed in dilute solution. Also presented is the predicted 
activity from HS-Adh-H monomers that would potentially be eroded from the bulk 
hydrogel during a 1 minute period at a rate of 390 pmole per minute per cm2 (black 
line). The predicted reaction profile of the eroded sample assumes: 1) the amount 
eroded in 1 minute occurs instantly at the initial time point; 2) the concentration of 
NAD+ is constant at 2000 µM; 3) only eroded monomers are active; 4) the amount of 
open buffer solution on top of the hydrogel sample is equal to 3.8 μL (the amount of 100 
mM 2,3-butanediol solution added to initiate the reaction); and 5) the reaction in the 
eroded volume occurs at the optimal reaction pH, pH 8.8.  
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Figure 2.12 Conversion of ‘in-gel’ NAD+ cofactor to NADH and again to NAD+. Twenty-
µL hydrogel of 10 wt% HS-Adh-H rehydrated with 2 mM NAD+ (final volume, wt% 
and concentration), heated to 60 °C, and buffered to pH 7 with 100 mM sodium 
phosphate. Twenty one-mM (in-gel concentration) of 2,3 butanediol added at t=0 to 
initiate the reduction of NAD+ to NADH. Twenty-mM 3-hydroxy-2-butanone added at 
t=10 mins. to initiate oxidation of in-gel NADH.  Sample pH and concentrations of 
substrates and cofactor were selected so that the equilibriums would favor near 
complete conversion of the limiting concentration of NAD+ to NADH upon addition of 
diol, and the oxidation of NADH to NAD+ upon ketone addition.   
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ChickenAKR   ----MAVPCMELNNKMKMPVLGLGTWQAP---------PGKVEEVVKHAIDAGYRHIDCA 47 
AdhD         MKRVNAFNDLKRIGDDKVTAIGMGTWGIGGRETPDYSRDKESIEAIRYGLELGMNLIDTA 60 
             
ChickenAKR   YFYQNEHEIGNAIKQKIKEGAVKREDLFVVTKLWNTFHEKSLVKEGCKRSLTALQLDYVD 107 
AdhD         EFYG-AGHAEEIVGEAIKE--FEREDIFIVSKVWPTHFGYEEAKKAARASAKRLG-TYID 116 
                             Loop A 
ChickenAKR   LYLMHYPMG-FKAGEELLPEDDKGMIIPSDTDFLDTWEAMEELVDCGKVKAIGISNFNHE 166 
AdhD         LYLLHWPVDDFKKIEETLH-------------------ALEDLVDEGVIRYIGVSNFNLE 157  
                Loop B 
ChickenAKR   QIERLLNKPGLKYKPVVNQIECHP---YLTQEKLIKYCHSKGIAVTAYSPLGSPNRPWAK 223 
AdhD         LLQRSQ-EVMRKYEIVANQVKYSVKDRWPETTGLLDYMKREGIALMAYTPLEKG------ 210 
             
ChickenAKR   PGEPMLLEDPKIKEIAARYHKTPAQVLIRFIIQRN-LAVIPKSDKQQRIKENMQVFDFEL 282 
AdhD         ----TLARNECLAKIGEKYGKTAAQVALNYLIWEENVVAIPKASNKEHLKENFGAMGWRL 266  
                                Loop C 
ChickenAKR   SKKEMDVILSFNRNWRAIPVPQSANHKDYPFNAEY 317 
AdhD         SEEDREMARRCV----------------------- 278 
 
Figure 2.13 Amino acid sequence alignment of AdhD from Pyrococcus furiosus 
(Q8TZM9) and a Chicken AKR (Q90W83) demonstrating the lack of substrate binding 
loops A, B and C commonly found in the AKR superfamily. The primary accession 
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BROADENING THE COFACTOR SPECIFICITY OF A THERMOSTABLE ALCOHOL 
DEHYDROGENASE USING RATIONAL PROTEIN DESIGN INTRODUCES NOVEL 
KINETIC TRANSIENT BEHAVIOR§ 
 
Abstract: Cofactor specificity in the aldo-keto reductase (AKR) superfamily has been 
well-studied, and several groups have reported the rational alteration of cofactor 
specificity in these enzymes. Although most efforts have focused on mesostable AKRs, 
several putative AKRs have recently been identified from hyperthermophiles. The few 
that have been characterized exhibit a strong preference for NAD(H) as a cofactor, in 
contrast to the NADP(H) preference of the mesophilic AKRs. Using the design rules 
elucidated from mesostable AKRs, we introduced two site-directed mutations in the 
cofactor binding pocket to investigate cofactor specificity in a thermostable AKR, AdhD, 
which is an alcohol dehydrogenase from Pyrococcus furiosus. The resulting double 
mutant exhibited significantly improved activity and broadened cofactor specificity as 
compared to the wild-type. Results of previous pre-steady state kinetic experiments 
suggest that the high affinity of the mesostable AKRs for NADP(H) stems from a 
conformational change upon cofactor binding which is mediated by interactions 
                                                 
§ A version of this chapter is published in Biotechnology and Bioengineering (2010), 107, 763-774, with co-
authors Ian Wheeldon and Scott Banta. EC designed the experiments, performed the experiments, 
analyzed data, and wrote the manuscript. 
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between a canonical arginine and the 2’-phosphate of the cofactor. Pre-steady state 
kinetics with AdhD and the new mutants show a rich conformational behavior that is 
independent of the canonical arginine or the 2’-phosphate. Additionally, experiments 
with the highly active double mutant using NADPH as a cofactor demonstrate an 
unprecedented transient behavior where the binding mechanism appears to be 
dependent on cofactor concentration. These results suggest that the structural features 
involved in cofactor specificity in the AKRs are conserved within the superfamily, but 
the dynamic interactions of the enzyme with cofactors are unexpectedly complex. 
 
Introduction 
The aldo-keto reductases (AKRs) are a family of oxidoreductases with a common (α/β)8-
barrel structure. They are found in almost every living system and catalyze a wide 
range of redox reactions (1, 2). Characteristic to this superfamily is a highly conserved 
cofactor binding pocket that binds a nicotinamide cofactor in the extended 
conformation without a Rossmann fold motif (3). Most members of the superfamily that 
have been studied exhibit a strong preference for NADP(H), suggesting a physiological 
role as reductases (4). 
Understanding the determinants of cofactor specificity of dehydrogenases has 
significant importance from an engineering perspective, as the native cofactor 
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specificity of these enzymes is often not ideal for use in synthetic metabolic pathways 
and other industrial applications.  Altering cofactor specificity of an enzyme in an 
artificial metabolic pathway can potentially correct a redox imbalance in a process or 
improve overall product yield, and therefore cofactor engineering is important in 
applications ranging from cofactor regeneration to bioelectrocatalysis (5-11). We are 
particularly interested in engineering these dehydrogenase enzymes for use in 
enzymatic biofuel cells, where the choice of the cofactor (acting as the electron mediator 
between the enzyme and the electrode) is of critical importance (12-14). 
Several groups have used site-directed mutagenesis to study the structural 
determinants of cofactor specificity in the AKRs (15-24) and there have been a few 
reports of the broadening of the cofactor specificity to increase the activity of these 
enzymes with NAD(H) (6, 25-28). Through these efforts, several hot spots for 
mutagenesis have been identified. The first is a lysine residue that appears partially 
buried under the bound cofactor and interacts with the pyrophosphate backbone, 
adenine ribose, and 2’-phosphate of NADP(H). This residue has been conservatively 
mutated in human aldose reductase (15, 24) and these studies suggest that interactions 
with the lysine are important for properly orienting the cofactor within the binding 
pocket and for positioning the nicotinamide head group for hydride transfer. Later, in 
an effort to improve the activity of an AKR with NADH, a lysine  glycine mutant was 
identified with improved kinetic properties (26).  
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A highly conserved arginine residue has also been shown to form important 
interactions with the adenosine 2’-phosphate. Studies mutating this canonical arginine 
have demonstrated a significant impact on activity with NADP(H), while changes with 
NAD(H) were minor (18, 22). The mechanism of cofactor binding in a model AKR, rat 
3α-hydroxysteroid dehydrogenase (3α-HSD), has been extensively studied and 
demonstrates a multi-step binding mechanism for the NADP(H) cofactor (22). A 
comparison of the crystal structures for the apo enzyme and the enzyme-NADPH 
binary complex suggests a conformational change takes place upon cofactor binding, 
similar to that observed in other AKRs (3, 29, 30). Using an argininemethionine 
mutant, it was demonstrated that the conformational change was due to the formation 
of a salt bridge between the arginine and 2’-phosphate of NADP(H), which could be 
observed as a fluorescence kinetic transient. No transient was observed in the 
argininemethionine mutant or when NAD(H) was used as a cofactor, suggesting this 
transient and corresponding conformational change were dependent upon interactions 
between the arginine and adenosine 2’-phosphate group (22). The stopped-flow 
fluorescence data was consistent with a two-step binding mechanism, where an initial 
rapid bi-molecular association is followed by a slow isomerization to a tightly bound 
complex. This serves to greatly increase the affinity of the enzyme for the cofactor, and 
locks the enzyme in a primed state ready to immediately act upon a substrate (19). In 
mutagenesis work performed with Cornybacterium 2,5-diketo-D-gluconic acid reductase 
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(2,5-DKGR), it was demonstrated that an argininehistidine mutant at this position 
increased activity with NADH while retaining activity with NADP(H) (26). The solved 
crystal structure of this mutant shows the histidine side-chain forms a π-stacking 
interaction with the indole ring of the cofactor, and a kinetic analysis demonstrated an 
improvement in the free energy of cofactor binding, consistent with the introduction of 
this stabilizing interaction. 
Newly available genome sequences from a variety of hyperthermophiles has led to the 
identification of several putative thermostable AKRs. Although few have been 
characterized, sequence alignments indicate that these thermostable AKRs contain a 
histidine residue in the cofactor binding pocket in place of the highly conserved 
arginine residue found at this position in mesophilic AKRs (Table 3.1). One such AKR, 
an alcohol dehydrogenase identified from the hyperthermophilic archaeon Pyrococcus 
furiosus (AdhD), exhibits a strong preference towards NAD(H) as a cofactor (31). The 
hyperthermophile sequence data and experimental evidence of the preference of AdhD 
towards NAD(H) combined with the arginine to histidine mutation identified in 
NADP(H)-biased AKRs seems to suggest that hyperthermophilic AKRs may 
preferentially utilize NAD(H).   
In the present work, we have rationally mutated the cofactor binding pocket in the 
thermostable AKR, AdhD, from Pyrococcus furiosus guided by the design rules 
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elucidated in the mesostable AKRs. A K249G/H255R double mutant exhibited the 
greatest improvement in activity with NADP(H), and also had superior activity with 
NAD(H) compared to the wild-type and the other enzyme variants tested. All enzyme 
forms also exhibited varying degrees of kinetic transients upon cofactor binding, in 
contrast to the previous results obtained with a mesostable AKR (22). Most 
interestingly, the highly active double mutant exhibited bi-exponential kinetic 
transients with NADPH where the direction of the fast transient was concentration 
dependent. Taken together, these results suggest that amino acids identified in the 
mesostable AKRs can be used to modify the cofactor specificity of AdhD, and the 
observed kinetic transients are independent of the formation of a guanido-phosphate 
salt bridge. 
 
Materials and Methods 
Chemicals and plasmids: Oligonucleotides were from Integrated DNA Technologies. 
The QuikChange Site Directed Mutagenesis kit was from Stratagene. Isopropyl-β-D-1-
thiogalactopyranoside (IPTG) was from Promega. E. coli BL21(DE3) competent cells 
were from New England Biolabs. Precast sodium dodecyl sulfate-polyacrylamide gels, 
NuPAGE MOPS running buffer, and broad-range molecular weight marker were from 
Invitrogen. All other chemicals were from Sigma-Aldrich and used without 
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modification. The Pyrococcus furiosus AdhD expression plasmid pWUR85 and tRNA 
helper plasmid pSJS1244 were a kind gift from Dr. John van der Oost (Wageningen 
University, The Netherlands) and are described in (31).  
Mutant Construction: Single mutants K249G and H255R and double mutant 
K249G/H255R were created using the QuikChange Site-directed Mutagenesis Kit (see 
SI). All mutations were verified by DNA sequencing. 
AdhD Expression and Purification: Expression and purification of AdhD followed a 
previously established protocol with minor modifications (31). After expression, cells 
were harvested by centrifugation, and pellets were resuspended in 1/10th volume 20 
mM Tris-HCl (pH 7.5) before being incubated at 80°C for 1 h. Endogenous proteins and 
cell debris were then removed by centrifugation for 20 min at 10,000 x g. The 
supernatant was retained as the heat-stable cell-free extract (HSCFE). Samples were 
concentrated over a centrifugal filter (30 kDa MWCO) before being applied to a gel 
filtration column (Superdex 16/200, GE Healthcare) equilibrated in 20 mM Tris HCl (pH 
7.8), 100 mM NaCl. Fractions containing active enzyme were pooled and concentrated. 
Enzyme stocks were diluted to working concentration in 20 mM Tris HCl (pH 7.8) 
before use. Expression and purification of AdhD mutants followed the same protocol. 
All enzyme concentrations were determined from A280 measurements with a calculated 
molar extinction coefficient of ε280 = 52495 M-1 cm-1. 
 84 
SDS-PAGE: Protein composition was analyzed using NuPAGE 4-12% Bis-Tris Gels 
with a Novex Mini-Cell system. Samples were prepared as described previously (31). A 
broad-range protein marker was used for molecular weight estimation.  
Homology Modeling: A homology model of AdhD was generated using ESyPred3D 
(32) and MODELLER with primary template prostaglandin F synthase from 
Trypanosoma brucei (1VBJ, 31.1% identities). Structures were analyzed using MolProbity 
(33) and verified against other members of the aldo-keto reductase superfamily. 
Cofactors were inserted into the binding pocket by aligning the backbone of the 
homology model with 2,5-DKGR from Corynebacterium (1A80 with bound NADPH, 
1M9H with bound NADH) (27). Figures were generated using YASARA. 
Activity Assays: The activity of each mutant was first examined at fixed substrate 
concentrations above the previously reported Michaelis constants for AdhD. Reaction 
mixtures containing 50 mM glycine (pH 8.8), 100 mM 2,3-butanediol (oxidation 
reaction) or 100 mM sodium phosphate (pH 6.1), 80 mM 3-hydroxy-2-butanone 
(reduction reaction) and enzyme were incubated in a 96-well UV-transparent 
microplate at 45°C in a SpectraMax M2 plate reader (Molecular Devices, Sunnyvale, 
CA). Reactions were initiated by the addition of 1-1000 µM cofactor. Initial rates were 
determined by following the production or depletion of NAD(P)H at 340 nm (ε = 6.22 
mM-1 cm-1). Data were collected in triplicate, and experiments were repeated three times 
with fresh solutions. All points were fit simultaneously to (Eq. 1) using non-linear least-
squares regression (Igor Pro, Wavemetrics, Inc.) to obtain estimates for the apparent kcat 
and Michaelis constant for each cofactor (34). Reported errors are standard deviations. 
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=                  Eq. 1 
Fluorescence Titrations: Dissociation constants for the enzyme-cofactor complexes 
were determined by fluorescence titration (22, 35, 36). Briefly, 2 µM enzyme in 50mM 
glycine (pH 8.8) (for NAD(P)+) or 10 mM potassium phosphate (pH 7.0) (for NAD(P)H) 
was stirred in a 1 cm quartz cuvette placed in a J-815 spectrometer (Jasco Inc., Easton, 
MD) equipped with a Peltier junction temperature control. Samples were excited at 280 
nm, and the fluorescence change upon cofactor binding was monitored at 330 nm 
(NAD(P)+) or 450 nm (NAD(P)H). The total volume of cofactor added was less than 1% 
of the reaction volume to limit dilution effects. Experiments were repeated in at least 
triplicate, and data were fit to a saturation adsorption isotherm.  
Steady-state Kinetics: The full kinetic parameters for the wild-type and double mutant 
AdhD were determined for both the oxidation and reduction reactions with 
NAD(P)(H). Initial rates at 45°C were measured using a SpectraMax M2 plate reader by 
following the production or depletion of NAD(P)H at 340 nm (ε = 6.22 mM-1 cm-1). 
Oxidation reactions contained 50 mM glycine (pH 8.8), 1-100 mM 2,3-butanediol, and 
the appropriate amount of enzyme and were initiated with 1-1000 µM NAD(P)+. 
Reduction reactions contained 100 mM sodium phosphate (pH 6.1), 1-100 mM 3-
 86 
hydroxy-2-butanone, and enzyme, and were initiated by the addition of 1-500 µM 
NAD(P)H. Some cofactor inhibition was observed at concentrations in excess of 1 mM 
(data not shown). Reactions were initiated with cofactor to limit cofactor degradation 
during incubation at elevated temperatures, however control experiments indicated 
that cofactor degradation was not significant over the time the reaction was monitored. 
Data were collected in at least triplicate, and were fit simultaneously to the ordered bi-
bi rate equation ((34), Eq. 2) using non-linear least-squares regression. This reaction 






=            Eq. 2 
Determination of Protein Stability: Unfolding was assessed by following the CD signal 
at 222 nm in a J-815 CD Spectrophotometer equipped with a Peltier junction 
temperature control. Scans were made over a range of guanidine hydrochloride 
(GdnHCl) concentrations with a 1°C min-1 temperature ramp from 25°C to 90°C. Prior to 
analysis, enzyme samples were allowed to equilibrate overnight at room temperature in 
the appropriate concentration of GdnHCl. The midpoint of a sigmoidal fit to the data at 
80 °C was taken as the denaturation midpoint.  
Kinetics of Cofactor Binding: The kinetics of cofactor binding were investigated using 
a SFM-20 stopped flow system (BioLogic Inc., Knoxville, TN) equipped with a 20 µl 
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fluorescence cuvette (dead time ≈ 13 ms) attached to a J-815 CD Spectrophotometer. All 
experiments were performed at 25°C. Samples of enzyme (0.75 µM) and cofactor (0.5 – 
30 µM) were mixed, and the quenching of intrinsic protein fluorescence (for NAD(P)+, 
320 nm cutoff) or the energy transfer between the protein and cofactor (for NAD(P)H, 
430 nm cutoff) was monitored upon exciting at 280 nm. Each fluorescence trace is the 
average of 3-5 shots, and each experiment was repeated three times with fresh 
solutions. Traces were fit to a mono-exponential or bi-exponential function where 
applicable, and the resulting rate constants were plotted versus cofactor concentration. 
These plots were used to obtain estimates of the rate constants for cofactor binding as 




Expression and Purification of AdhD: Site-directed mutagenesis was used to create 
three new mutant AdhD enzymes, K249G, H255R, and K249G/H255R. The wild-type 
and new mutant AdhDs expressed in high yields in E. coli and were readily purified 
due to their extreme thermostabilities. A simple and rapid purification scheme 
consisting of heating the re-suspended cell pellets to both lyse the cells and denature 
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endogenous proteins, followed by centrifugation, concentration, and size exclusion 
chromatography yielded homogenous samples as judged by SDS-PAGE (Figure 3.6). 
Homology Modeling: Previous work and structural insights guided the decision to 
create the two single mutants and the double mutant of the thermostable AKR AdhD. 
In order to visualize the potential impact of these mutations on the cofactor binding 
pocket, a homology model was created. The highly conserved structure of the AKR 
superfamily enabled the addition of cofactors into the homology model by alignment 
with crystal structures of a similar AKR (2,5-DKGR) containing bound cofactor. The 
structural alignment had a RMSD of 1.0Å over 232 aligned residues, and allowed us to 
identify amino acids that could potentially interact with the cofactor (Figure 3.1). It 
seems likely that His255 is in position to form a stacking interaction with the adenine 
ring of the cofactor, and potentially an ionic interaction with the 2’-phosphate of 
NADP(H) as well. Additionally, replacement of Lys249 with glycine should increase the 
volume of the cofactor binding pocket and allow for increased conformational 
flexibility.  
Fluorescence Titrations: The new mutations were made to impact cofactor binding and 
thereby cofactor specificity. Conveniently located tryptophan residues in the cofactor 
binding pocket allow for the determination of cofactor dissociation constants for the 
different mutants by fluorescence titration (Table 3.5). Comparison of dissociation 
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constants between the wild-type enzyme and mutants can then be used to calculate the 
changes in ground state cofactor binding energies. At 25°C, the H255R mutant lost 0.2 
kcal/mol of binding energy with NAD+ but gained 2.6 kcal/mol with NADP+. The 
change in binding energy with NADP+ is less than was observed in an 
argininemethionine mutant of 3α-HSD (22), but is comparable in magnitude to the 
gain of an electrostatic interaction. The K249G single mutant gained 2.2 and 2.4 kcal/mol 
of binding energy with NAD+ and NADP+, respectively, while the K249G/H255R double 
mutant exhibited a slight gain of 0.5 kcal/mol for NAD+ and a larger gain of 2.1 kcal/mol 
with NADP+. Small gains in binding energies were observed with the reduced cofactors 
in every case, ranging from 0.14 kcal/mol with NADPH for the K249G mutant to 0.57 
kcal/mol with NADPH for the H255R mutant. The double mutant gained 0.31 kcal/mol 
with NADH and 0.25 kcal/mol with NADPH. 
Fluorescence titrations were also performed at 45°C with wild-type AdhD and the 
K249G/H255R mutant to allow for comparison with the Kia term of the ordered bi-bi 
rate equation obtained from steady-state kinetic experiments as described below (Table 
3.2).  
Steady-State Kinetic Analysis: A simplified kinetic analysis of the oxidation and 
reduction reactions for the wild-type enzyme and the three mutants was performed at a 
fixed substrate concentration (Table 3.6). In order to estimate the effect of the mutations 
 90 
on cofactor specificity, the apparent catalytic efficiency (kcat/KA) was compared (Figure 
3.2). In the oxidation reaction, the wild-type enzyme exhibits a similar preference for 
both NAD+ and NADP+. No significant difference in catalytic efficiency between the 
mutants and the wild-type with either cofactor was observed. However, the H255R 
mutant demonstrated a 2-fold preference for NADP+ over NAD+, which agrees with the 
proposed role of Arg255 in NADP(H) binding. For the double mutant in the two 
oxidation reactions, the Michaelis constants for the substrate (KB) were later calculated 
to be greater than the substrate concentration utilized, and therefore the assumption of 
saturating substrate in these cases is invalid which would lead to an underestimation of 
the kcatapp. 
In the reduction reaction, larger changes in the apparent kinetic parameters were 
observed. The wild-type enzyme exhibited significant specificity for NADH over 
NADPH as evidenced by an order of magnitude difference in the catalytic efficiency. 
For the H255R mutant, the catalytic efficiency doubled with NADH as compared to the 
wild-type and it increased by an order of magnitude with NADPH so that the mutant 
had no significant specificity between the cofactors. For the K249G mutant, the catalytic 
efficiency increased 5-fold for NADH while the efficiency with NADPH increased more 
than 30-fold in comparison to the wild-type. For the double mutant, the catalytic 
efficiency with NADH increased 4-fold while the efficiency with NADPH increased 
more than 16-fold. 
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Since the double mutant exhibited the largest increase in the apparent kcat with both 
cofactors, the full steady-state kinetic experiments were performed for this mutant and 
compared to the values for the wild-type enzyme (Table 3.2, Figure 3.7). In the 
oxidation reaction, the kcat with NAD+ improved by 15-fold for the double mutant over 
the wild-type enzyme. The impact on activity with NADP+ was even greater, as the 
double mutant had a kcat nearly two orders of magnitude larger than the wild-type. 
However, the Michaelis constant for the cofactor also increased significantly in both 
cases, from 63 µM to 460 µM for NAD+ and from 5.1 µM to 78 µM for NADP+ in the 
wild-type and double mutant, respectively. The Michaelis constant for the substrate 
also increased significantly, from 29 mM for the wild-type to 690 mM for the double 
mutant with NAD+, and from 1.3 mM to 200 mM with NADP+. In the reduction 
reaction, the double mutant has a kcat 3-fold greater with NADH and 6-fold greater with 
NADPH compared to the wild-type. While the Michaelis constants for the cofactor and 
substrate increased for the double mutant in the oxidation reaction, they mostly 
decreased in the reduction reaction. For the cofactor, KA with NADH decreased from 
190 µM to 50 µM, and with NADPH the value decreased from 280 µM to 33 µM. The KB 
value increased from 0.9 mM to 13 mM when NADH was the cofactor, but decreased 
from 6.7 mM to 5.0 mM when NADPH was the cofactor. In the case of the reduction 
reaction with NADPH, the Kia values were unable to be fit by the model and so the KD 
values obtained by fluorescence titration at 45°C were used instead. 
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In order to simplify the comparison of the impact of the mutations on the steady-state 
kinetics, the parameters were used to estimate the microscopic rate constants for the 
simplified reaction mechanism described in Equation 3 (Table 3.3). Generally, the on-
rate of the cofactor (k1ss) increased by 2 to 10-fold in the double mutant compared to the 
wild-type. In most cases the off-rate (k2ss) was found to decrease, except in the case of 
the double mutant with NADPH where the off-rate increased. The net on-rate of the 
substrate (k3ss) in the oxidation reaction was only slightly impacted by the mutations, 
whereas a much stronger effect was observed in the reduction reaction. The on-rate of 
the substrate with NADH decreased almost 5-fold in the double mutant versus the 
wild-type, but increased 8-fold with NADPH. The ratio of k1ssk3ss/k2ss is a convenient 
single parameter for examining the catalytic performance of the mutants (9). When 
judged by this composite rate constant, the double mutant enzyme is shown to be 
substantially improved with NADP+ in the oxidative direction and with both NADH 













3+             Eq. 3 
Determination of Enzyme Stability: Guanidine denaturation curves were generated for 
wild-type AdhD and the K249G/H255R double mutant in order to assess the effect of 
the mutations on enzyme stability. Both enzymes appeared stable in up to 6M GdnHCl 
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at room temperature, and temperatures greater than 70°C were required to observe an 
unfolding transition. At 80°C, the denaturation midpoints of both enzymes were 
comparable (4.8M for the wild-type, K249G and H255R mutants and 4.9M for the 
K249G/H255R mutant), suggesting that the mutations had little effect on stability 
(Figure 3.8). The unfolding did not appear to be reversible, however, as little CD signal 
was regained upon cooling. Thus this data could not be used to calculate ΔG values.  
Kinetics of Cofactor Binding: Stopped-flow fluorescence spectroscopy was used to 
further investigate the mode of cofactor binding in the wild-type and mutant enzymes 
(16, 35, 39). AdhD contains six tryptophan residues, two of which are located near the 
active site. These residues act as distal reporters of cofactor binding, as the quenching of 
intrinsic protein fluorescence or energy transfer with the reduced cofactor can be 
followed (Figure 3.4). The signal voltage is inversely proportional to the fluorescence 
intensity, such that negative amplitude corresponds to an increase in fluorescence and 
vice versa. In this study, all four enzymes tested displayed observable fluorescence 
transients with NADP(H), and all except H255R displayed observable transients with 
NAD(H) (Figure 3.9). In some cases, transients may have occurred mostly within the 
dead-time of the stopped-flow (such as H255R with NADH), and in these cases no rate 
data were obtained. The existence of transients in these cases was confirmed by control 
stopped-flow experiments diluting the enzyme into buffer and by comparison with the 
steady-state fluorescence titration data. Plots of the observed rate constant versus 
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cofactor concentration displayed saturation kinetics and were well fit by a hyperbolic 
function (Table 3.4, Figure 3.10). These are consistent with a two-step binding 
mechanism (Eq. 4), in which a rapid bimolecular association step is followed by a slow 
isomerization step (35, 38). Note that the cofactor binding constants k1ss and k2ss 
obtained from analysis of the steady-state kinetics data include the isomerization step 














*           Eq. 4 
Unprecedented Transients with the Double Mutant and NADPH: Fluorescence traces 
of NADPH binding with the double mutant exhibited cofactor concentration dependent 
amplitudes and were best fit with a bi-exponential function. Three regimes were 
identified based on the amplitude and direction of the fast transient, as the rate of the 
slow transient remained relatively constant (Figure 3.5). At low NADPH concentrations 
(< 2 μM), the fast transient had a negative amplitude, consistent with an increase in 
FRET efficiency as the nicotinamide head group binds near the active site. At slightly 
higher concentrations, the amplitude of this fast transient was too small to be reliably fit 
with a rate constant. Above 5 μM NADPH the amplitude of the fast transient became 
positive, indicating an initial rapid decrease in fluorescence. Interestingly, a hyperbolic 
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fit to the rates of the fast transient in the first regime extrapolates roughly to the 
measured rates of the fast transients in the third regime (Figure 3.5).  
 
Discussion 
Knowledge of the cofactor binding mechanism and determinants of cofactor specificity 
obtained with mesostable AKRs allowed us to readily broaden the cofactor specificity in 
a thermostable AKR, AdhD. As an argininehistidine mutation has been previously 
demonstrated to increase activity with NAD(H), we reasoned the reverse would hold 
and that a histidinearginine mutation would increase activity with NADP(H). 
Additionally, a lysineglycine mutation was investigated as it was previously found to 
improve overall activity (9, 26). Combining both mutations in 2,5-DKGR yielded a 
double mutant with significantly improved kinetic properties (9).   
In the present work with AdhD, the H255R single mutant exhibited an increased 
binding affinity toward NADP+ and a concomitant reduction in affinity for NAD+. A 
similar trend was observed using a simplified kinetic analysis, as the apparent kcat for 
H255R was only about 60% of that of the wild-type with NAD+, but was six-fold higher 
than the wild-type with NADP+. These results support the idea that an arginine at 
position 255 is important for recognizing NADP(H), but is not the sole determinant of 
cofactor specificity. 
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Kinetics with the K249G single mutant demonstrated a significant increase in kcat 
compared to both the wild-type and the H255R single mutant with NAD(P)+ and 
NADH. Previous kinetic and structural studies suggest this residue is important in 
properly orienting the cofactor in the active site (9, 15, 24, 26). As the natural substrates 
for 2,5-DKGR and AdhD are not known, it is possible this mutation better positions the 
cofactor for turnover with the non-natural substrates and would impair wild-type 
functionality. These mutations do not seem to have an additive effect on cofactor 
binding energy in AdhD, however, as the double mutant only exhibits a slight increase 
in affinity for NAD+ and a moderate increase in affinity for NADP+, which is less than 
would be expected given the changes in binding affinities observed in the single 
mutants. Regardless, the K249G/H255R double mutant was significantly more active 
than the wild-type and single mutant enzymes with both NAD(H) and NADP(H) both 
at moderate (Table 3.6) and high temperatures (Table 3.7), and these mutations slightly 
improved the thermostability of the enzyme (Figure 3.8). This impressive result 
confirmed the design rules established for relaxing cofactor specificity in AKRs and 
prompted us to further investigate the basis for this change and whether mesostable 
and thermostable AKRs share a conserved cofactor binding mechanism.  
Given the increase in kcat observed in the K249G/H255R double mutant, it is useful to 
compare individual rate constants rather than overall catalytic efficiencies (Table 3.3, 
Figure 3.3). The composite parameter (k1k3/k2)ss highlights the significant improvement in 
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activity and broadened specificity observed with the K249G/H255R double mutant over 
the wild-type enzyme. Further, the double mutant exhibits an order of magnitude 
improvement in this parameter when NADP+ is used as the cofactor in place of NAD+. 
This is largely a result of a decrease in the off-rate of NADP+, likely due to anchoring of 
the 2’-phosphate by Arg255 as has been previously proposed. 
Stopped-flow fluorescence spectroscopy has been used to probe the difference in 
binding mechanism between NADP(H) and NAD(H) in rat liver 3α-HSD and suggests 
the canonical arginine residue forms an electrostatic linkage with the 2’-phosphate of 
NADP(H), which is observed as a fluorescence kinetic transient (22). The interaction is 
accompanied by a conformational change in the cofactor binding pocket which 
increases the affinity of the enzyme for the cofactor. A kinetic transient was not 
observed in an argininemethionine mutant or when NAD(H) was used as a cofactor, 
suggesting that the transient (and associated conformational change) was both arginine 
and 2’-phosphate dependent.  
Introduction of the canonical arginine residue into AdhD allowed us to examine 
whether the cofactor binding mechanism established in the 3α-HSD enzyme applies to 
the thermostable AdhD.  Unexpectedly, the reported arginine and 2’-phosphate 
dependent fluorescence transient observed upon cofactor binding in the mesostable 
AKRs does not seem to hold for AdhD. In the present work, we demonstrate that a 
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kinetic transient exists in wild-type AdhD which contains a histidine at this position, 
and also when NAD(H) is used as a cofactor. Similar behavior was observed in the 
three cofactor binding pocket mutants used to further investigate cofactor specificity, 
suggesting this conformational behavior is less sensitive to the presence of the arginine 
residue and 2’-phosphate of NADP(H) than previously suggested. Additionally, when 
protonated, the histidine mutation is relatively conservative compared to the previously 
described methionine mutants. This could explain the existence of fluorescence kinetic 
transients with both the wild-type and H255R enzymes upon NADP(H) binding, as the 
histidine may be able to form an electrostatic linkage with the negatively charged 2’-
phosphate of the cofactor similarly to the canonical arginine. Further exploration of 
these mutations in mesophilic AKRs, especially the transient behavior of His255 and 
Gly249 mutants, would lead to a better understanding of these differences. Also, it will 
be interesting to see whether other thermostable AKRs demonstrate a similar cofactor 
binding mechanism. 
Unprecedented transient behavior was observed in the K249G/H255R double mutant 
when NADPH was used as a cofactor. Fluorescence traces appeared to be at least bi-
exponential, and the amplitude of the fast transient was surprisingly dependent on the 
concentration of the cofactor. At low NADPH concentrations (< 2 µM), a fast increase in 
fluorescence intensity was followed by a slow decay to the steady-state value. As the 
fluorescence signal is due to energy transfer between the enzyme and cofactor, this 
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suggests an initial rapid binding step that brings the nicotinamide head group close to 
the active site, followed by a slow isomerization moving the head group away to an 
equilibrium position. As the cofactor concentration increased, the amplitude of the fast 
transient decreased to the point where the signal was dominated by the slow transient. 
Above 5 µM NADPH, a fast transient was again observed, but with an amplitude 
opposite of that at lower cofactor concentrations. A plot of the fast transient observed in 
regime I versus NADPH concentration is best fit by a hyperbola, suggesting at least a 
three step reaction mechanism (36, 38). To the best of our knowledge, this behavior has 
not been previously reported in the literature. 
The dynamics of NADPH binding suggest the cofactor samples several configurations 
before reaching an equilibrium position. The increased volume of the cofactor binding 
pocket afforded by the lysineglycine mutation seems likely to contribute to the 
increased conformational flexibility of the cofactor. Multiple cofactor molecules 
competing for the same binding site could also explain the inverse amplitude observed 
above 5 µM NADPH, but this does not agree with the steady-state kinetics where 
cofactor inhibition was only observed at cofactor concentrations several orders of 
magnitude higher (data not shown).  
Estimates of cofactor dissociation constants were obtained through three orthogonal 
methods: fluorescence titrations, steady-state kinetics, and transient-state kinetics. Fits 
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to the ordered bi-bi rate equation (Eq. 2) were used to determine the full steady-state 
kinetic parameters for the wild-type and K249G/H255R double mutant. The fit 
parameter Kia is equivalent to the dissociation constant of the enzyme-cofactor complex 
(34), and was generally in good agreement with the dissociation constant as measured 
by fluorescence titrations (Table 3.2). The transient-state kinetics investigated by 
stopped flow fluorescence spectroscopy can also be used to calculate the microscopic 
rate constants corresponding to each step in the cofactor binding mechanism (38). The 
overall dissociation constant can then be calculated from the microscopic rate constants, 
and compared to that obtained by fluorescence titrations (35). These results are 
summarized in Table 3.4. Almost universally, the dissociation constants calculated from 
the microscopic rate constants significantly underestimate those obtained by 
fluorescence titration and steady-state kinetics. Although the source of this disparity is 
unknown, some difficulty in reconciling stopped-flow fluorescence data with that 
measured at steady-state has been reported by others (21, 22, 29, 40). Control 
experiments were performed to rule out artifacts due to mixing effects, non-specific 
binding, or photobleaching with the fluorescence methods, and the introduction of 
additional steps in the cofactor binding mechanism could only further decrease the 
calculated dissociation constants. Further experiments using T-jump spectroscopy or 
ITC may be necessary to reconcile these observations and fully elucidate the cofactor 
binding mechanism. 
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Broadening cofactor specificity in the AKR superfamily has become almost formulaic, 
although the mechanism of cofactor binding does not yet seem to be fully elucidated. 
The ability to change or relax the cofactor specificity of AKRs will be useful in industrial 
applications, as NAD(H) is more stable and less expensive than NADP(H) (8), and the 
use of AKRs in specialized applications will benefit from knowledge obtained during 
cofactor specificity engineering exercises, as it may be advantageous to increase activity 
with non-natural cofactors that are optimized for the final application (41). 
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Tables and Figures 
 
Table 3.1: Multiple sequence alignment of cofactor binding pocket residues of 
selected mesostable and thermostable AKRs. 
 
Protein Origin Residue… 24 50 166 167 190 216 219 221 270 271 272 276 279 280
1 aldehyde reductase Human W D S N Q Y L S K S I R Q N
2 3α-HSD Rat T D S N Q Y L S R S F R E L
3 2,5-DKGR Mesostable bacterium F D S N Q W L Q K S V R E N
4 AdhD Thermostable archaeon W D S N Q Y L K K A S H E N
5 Putative AKR Thermostable archaeon W D S N Q Y L K K A I H E N
6 Putative AKR Thermostable archaeon Y D S N Q W L H R A S H E N
7 Putative AKR Thermostable bacterium Y D A T Q A L V G M S H E N
  
Rat liver 3α-HSD numbering, the shaded positions correspond to AdhD residues 249 
and 255 as mutated in this study. 1. Human aldehyde reductase (Accession #P14550), 2. 
Rat liver 3α-hydroxysteroid dehydrogenase (Accession #P23457), 3. Corynebacterium 2,5-
diketo-D-gluconic acid reductase A (Accession #P06632), 4. Pyrococcus furiosus alcohol 
dehydrogenase D (Accession #NP_579689), 5. Putative AKR from Thermococcus 
barophilus (Accession #EDY40262), 6. Putative AKR from Thermococcus volcanium 




Table 3.2: Full steady state kinetic parameters for wild type AdhD and the 
K249G/H255R double mutant 
 
 
Oxidation reactions were performed at 45°C in 50 mM glycine (pH 8.8) with 2,3-
butanediol substrate. Reduction reactions were performed at 45°C in 100 mM sodium 
phosphate (pH 6.1) with 3-hydroxy-2-butanone substrate. KD is the cofactor dissociation 
constant as determined by fluorescence titration under the same conditions. KA and KB 
are the Michaelis constants for the cofactor and substrate, respectively (Equation 2). 
Reactions were performed in at least triplicate, and errors are standard deviations. ND: 
The Kia term was unable to be fit by the model, and was instead set equal to the 
measured KD (34). 
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Table 3.3: Microscopic rate constants calculated from steady-state kinetic parameters. 
 
Rate constants calculated from the relationships: k1ss = kcat/KA, k2ss = kcatKia/KA, and k3ss = 




Table 3.4: Comparison of cofactor dissociation constants measured by fluorescence 
titrations and stopped-flow fluorescence spectroscopy 
 
Dissociation constants were calculated as previously described from hyperbolic fits to 
the observed rate constants of the kinetic transients versus the cofactor concentrations 
(Figure 3.5, Figure 3.10). Measured dissociation constants were obtained by fluorescence 
titrations performed under the same conditions as the stopped flow experiments. NA: 




Figure 3.1: Homology model of the AdhD cofactor binding pocket with bound 
cofactors 
Homology model of AdhD with bound NAD(H) (left) and NADP(H) (right). Side 
chains of Lys249 and His255 of the wild-type AdhD are shown in purple, and Arg255 of 
the double mutant is shown in yellow. His255 is in position to form a stacking 
interaction with the adenine moiety of the cofactor, while Arg255 can form an 
electrostatic interaction with the 2’-phosphate in NADP(H). Lys249 extends beneath the 





Figure 3.2: Apparent catalytic efficiencies (kcat / KM)app of wild-type AdhD and 
mutants in the oxidation and reduction reactions. 
Apparent catalytic efficiencies determined under fixed substrate conditions were 
calculated using Equation 1. Reaction mixtures contained 50 mM glycine (pH 8.8), 100 
mM 2,3-butanediol, 1-1000 μM NAD(P)+, and enzyme (oxidation reaction, A) or 100 mM 
sodium phosphate (pH 6.1), 80 mM 3-hydroxy-2-butanone, 1-500 μM NAD(P)H, and 
enzyme (reduction reaction, B) at 45°C. Measurements were performed in triplicate, and 
experiments were repeated three times with fresh solutions. Error bars are standard 
deviations. Asterisks indicate statistically significant difference from wild-type AdhD at 
p < 0.05. +: fits to Equation 3 suggest substrate concentration is not saturating, thus the 




Figure 3.3: Activity of wt AdhD and K249G/H255R with each cofactor 
Microscopic rate constants calculated from the steady-state kinetic parameters (Table 
3.3). Comparing the value of (k1k3/k2)ss demonstrates the significant improvement in 






Figure 3.4: Fluorescence kinetic transients observed upon cofactor binding for the K249G 
AdhD mutant 
Representative fluorescence traces of K249G AdhD mutant (0.75 µM) with (A) 7.5 µM NADH 
and (B) 7.5 µM NAD+ fit to a mono-exponential function. (C) Plot of the observed rate constant 
as a function of cofactor concentration for K249G AdhD with NAD+. Error bars are standard 
deviations of at least three independent measurements. The data was fit with a hyperbola to 
obtain estimates of the microscopic rate constants (Table 3.4). 
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Figure 3.5: Identification of three regimes of kinetic transients observed upon 
NADPH binding to the K249G/H255R double mutant 
The observed rate constants for the fast and slow fluorescence transients observed upon 
mixing 1.5μM K249G/H255R with NADPH. Samples were excited at 280 nm, and 
fluorescence of the cofactor due to energy transfer from tryptophan residues was 
detected through a 430 nm cutoff filter. A hyperbola was fit to the fast transient in the 
first regime (≤ 2 μM NADPH), and was extrapolated to the third regime. Inset plots 
contain representative fluorescence traces from each regime. In regime I, a fast increase 
in fluorescence is followed by a slow decay to the steady-state value. In regime II, the 
amplitude of the fast transient is too small to obtain an estimate, and the slow transient 
dominates the signal. In regime III, a fast initial decay is followed by a slow decay to the 
steady-state value. These results are consistent with a concentration-dependent reversal 
in the direction of the reorientation that occurs in the cofactor binding pocket during the 






Oligos used for site-directed mutagenesis (mutations in italics): 
 
K249Gs:  
5'- GGA AAA TGT TGT AGC AAT TCC AGG AGC AAG CAA CAA GGA ACA CC -3' 
K249Gas:  
5'- GGT GTT CCT TGT TGC TTG CTC CTG GAA TTG CTA CAA CAT TTT CC -3' 
H255Rs:  
5'- CCA AAA GCA AGC AAC AAG GAA CGC CTC AAA GAA AAC TTT GG -3' 
H255Ras:  










Table 3.6: Apparent Kinetic Parameters in the Oxidation and Reduction Reactions. 
Oxidation reaction performed at 45°C in 50 mM glycine (pH 8.8) with 100 mM 2,3-
butanediol as the substrate. Reduction reaction performed at 45°C in 100 mM sodium 
phosphate (pH 6.1) with 80 mM 3-hydroxy-2-butanone as the substrate. Statistically 
significant difference between values obtained with NAD(H) and NADP(H) for a 
particular mutant are indicated by italics, statistically significant difference from the 
values obtained with the wild-type enzyme are indicated by asterisks (*). Statistical 
significance was reached at a p value < 0.05.  
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Table 3.7: Apparent Kinetic Parameters in the Oxidation Reactions at 70 °C. 
Oxidation reaction performed at 70°C in 50 mM glycine (pH 8.8) with 100 mM 2,3-
butanediol as the substrate. The change in absorbance at 340nm was monitored using a 
Jasco J-815 spectrometer in a 1cm stirred quartz cuvette, and data were fit 
simultaneously to Eq. 1. Reported errors are standard deviations. NA: The observed 
activity of the wt AdhD with NADP+ at the above conditions was <0.5 s-1, and a value 









Figure 3.6: SDS-PAGE analysis of heterologously expressed AdhD and mutants after 
gel filtration.  
MW: molecular weight marker, lane 1: wt AdhD, lane 2: K249G, lane 3: H255R, lane 4: 
K249G/H255R. Samples were prepared by heating for 1 h at 100°C in the presence of 
sample buffer (see text). A single band is observed at ~32 kDa, consistent with the 






Figure 3.7: Ordered bi-bi Kinetics Fits 
Plots of ordered bi-bi rate equation fits to steady-state kinetics data for the wild type 




Figure 3.8: GdnHCl Denaturation Curves 
CD signal at 222 nm for the wild type AdhD (blue, open circles), K249G AdhD (green, 
open squares), H255R AdhD (black, open triangles) and the K249G/H255R mutant (red, 
closed circles) at 80°C as a function of GdnHCl concentration. Lines are least-squares 
fits using a sigmoidal function to obtain the denaturation midpoint. Fits are only shown 
for the wild-type and K249G/H255R mutant curves for clarity. Wild-type AdhD, K249G 
AdhD, and H255R AdhD have an apparent denaturation midpoint of 4.8M GdnHCl 
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AN ENZYMATIC BIOFUEL CELL UTILIZING A BIOMIMETIC COFACTOR§ 
 
Abstract: The performance of enzyme-based biofuel cells, biosensors, and 
bioelectrocatalytic systems is often limited by poor mass transport within immobilized 
architectures and poor cofactor regeneration kinetics. As the dehydrogenase enzymes 
commonly used in these applications require a nicotinamide cofactor as an electron 
mediator, we have explored the use of biomimetic cofactors with higher diffusion 
coefficients to address these limitations. Here, we demonstrate a biofuel cell anode 
constructed with an engineered dehydrogenase enzyme capable of utilizing 
nicotinamide mononucleotide (NMN+) to oxidize D-arabinose. While the enzymatic 
activity with NMN+ is significantly reduced as compared to NAD+, the maximum 
power density of the biofuel cell is comparable for both cofactors. Additionally, an 
increase in the limiting current is observed with NMN(H), suggesting increased 
cofactor diffusion. While protein engineering efforts have often focused on improving 
the kinetics of wild-type enzymes, this work suggests that significant performance gains 
can be obtained by engineering enzymes for activity with biomimetic cofactors with 
                                                 
§ A version of this chapter has been submitted to Nature Communications with co-authors Matthew Meredith, 
Shelley Minteer, and Scott Banta. EC and MM contributed equally to this work and are co-first authors. 
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desirable properties, such as improved diffusion and faster cofactor regeneration 
kinetics at electrode surfaces. 
 
Introduction 
Immobilization of enzymes in polymer films has been used extensively in bioelectrode 
and biosensor applications (1-3). Compared to soluble enzyme systems, the use of 
immobilized enzymes reduces the amount of protein required and greatly increases the 
stability and lifetime of the system (4). Nafion®, a perfluorosulfonated ion-exchange 
polymer, has been widely used in these systems, as it provides a mechanically and 
chemically stable layer that can be easily cast onto an electrode surface. Further, 
modifying the Nafion® membrane by casting in the presence of quaternary ammonium 
salts has been shown to increase mass transport through the film (1, 5, 6). This also 
provides a more favorable pH environment for the immobilized enzymes, as the 
superacid character of the polymer is reduced through the exchange of protons on the 
sulfonic acid groups. While these modified Nafion® membranes provide improved mass 
transport compared to unmodified films, cofactor diffusion has still been suggested to 
be rate-limiting in these systems (7). In order to address this significant limitation, we 
have examined the use of minimal cofactor analogs to improve performance through an 
increased diffusion rate.  
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Typically, enzymes possess a high specificity for their natural cofactor, which allows 
them to perform a variety of chemistries in vivo. As such, wild-type enzymes generally 
exhibit very poor activity with non-native biomimetic cofactors, and there have been 
few reports of engineering enzymes for this novel activity. The most notable work in 
this area has been performed by Fish et al., who tested a series of N-benzylnicotinamide 
derivatives and β-nicotinamide-5’-ribose methyl phosphate for the stereospecific 
reduction of a variety of compounds by horse liver alcohol dehydrogenase, with 
concomitant cofactor regeneration catalyzed by [Cp*Rh(bpy)(H)]+ and formate (8). 
However, the observed activities were extremely low (≈28 d-1), and the investigated 
cofactor analogues were sensitive to oxidation. A later set of experiments performed 
with bacterial Cytochrome P450s  and 2-hydroxybiphenyl 3-monooxygenase (HbpA) 
yielded much higher activities, and a few previously reported cofactor specificity 
mutants were able to utilize the nicotinamide derivatives with better than wild-type 
activity (9, 10). 
Previously, we engineered a thermostable NAD(H)-dependent alcohol dehydrogenase 
from Pyrococcus furiosus (AdhD) for broadened cofactor specificity and improved 
activity (11). The engineered enzyme contains two mutations to the cofactor binding 
pocket obtained by rational design. One, a histidine to arginine mutation (H255R), is 
positioned in a cleft distal to the active site where the adenine indol of the natural 
cofactor (and the 2’-phosphate of NADP(H)) binds, and has been shown to be important 
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in determining cofactor specificity (12).  The other, a lysine to glycine mutation (K249G), 
is located in the bottom of the cofactor binding pocket along the pyrophosphate 
backbone of the cofactor (13, 14). Previous work suggests the elimination of this bulky 
lysine side chain increases the conformational flexibility of the cofactor in the binding 
pocket, and allows for an increased turnover rate and broadened specificity (12-15). 
Analysis of the two single AdhD mutants supports this hypothesis, with the H255R 
mutation increasing activity with NADP(H), while the K249G mutation improves 
activity with both cofactors (11). 
We subsequently discovered that the engineered double mutant AdhD was able to 
utilize the minimal cofactor nicotinamide mononucleotide (NMN+) for catalysis. NMN+ 
represents the electroactive half of a natural nicotinamide cofactor, cleaved at the 
pyrophosphate backbone, and differs from the previously studied β-nicotinamide-5’-
ribose methyl phosphate only by the lack of the methyl group (Figure 4.1a). Here we 
describe the effect of using this biomimetic cofactor in a biofuel cell as compared to the 




Materials and Methods 
Chemicals: NAD+, NMN+, neutral red, Nafion® 1100EW suspension, and all salts were 
purchased from Aldrich and used as received. Nafion® modified with 
tetrabutylammonium bromide (modified Nafion®) was prepared according to a 
previous protocol (5). All other chemicals were from Sigma-Aldrich and used without 
modification.  
Protein Expression and Purification: Expression and purification of wt AdhD, K249G 
AdhD, H255R AdhD, and the K249G/H255R AdhD double mutant followed a 
previously established protocol (11). Purity was assessed by SDS-PAGE and 
standardized activity assays, and purified enzyme was stored lyophilized. All enzyme 
concentrations were determined from A280 measurements with a calculated molar 
extinction coefficient of ε280 = 52495 M-1 cm-1 and confirmed using the BCA Protein Assay 
Kit (Thermo Fisher Scientific, Rockford, IL). 
Fluorescence Titrations: Dissociation constants for the enzyme-cofactor complexes 
were determined by fluorescence titration (16-18). Briefly, 2 µM enzyme in 50mM 
glycine (pH 8.8) was stirred in a 1 cm quartz cuvette placed in a J-815 spectrometer 
(Jasco Inc., Easton, MD) equipped with a Peltier junction temperature control. Samples 
were excited at 280 nm, and the fluorescence quenching upon cofactor binding was 
monitored at 330 nm. The total volume of cofactor added was less than 1% of the 
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reaction volume to limit dilution effects. Experiments were repeated in at least 
triplicate, and data were fit to a saturation adsorption isotherm.  
Steady-state Kinetics: The full kinetic parameters for the K249G/H255R double mutant 
AdhD were determined with both NAD+ and NMN+ using 2,3-butanediol or D-
arabinose as a substrate. Initial rates at 25°C were measured using a SpectraMax M2 
plate reader by following the production of the reduced cofactor at 340 nm (ε340 = 6.22 
mM-1 cm-1). Reactions contained 50 mM glycine (pH 8.8), 1-100 mM substrate, and the 
appropriate amount of enzyme and were initiated with 1-1000 µM NAD+ or 50-2500 µM 
NMN+. Data were collected in at least triplicate, and were fit simultaneously to the 
ordered bi-bi rate equation (Eq. 1) (19) using non-linear least-squares regression. This 









          (1)  
Electrode Fabrication: Glassy carbon rotating disc electrodes (5 mm diameter) were 
purchased from Pine Instruments and a Pine Rotator (Model AFM-SRX) was used for 
all rotating experiments.  Electrochemical measurements were taken with a CH 
Instruments model 810 potentiostat interfaced with a PC.  All voltammetric experiments 
were carried out using a platinum mesh counter electrode and a saturated calomel 
reference electrode (SCE). Neutral red was electropolymerized according to previously 
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published protocols (21, 22) as follows:  Neutral red (11.5 mg) was dissolved into 100 
mL of a pH 6 buffer solution consisting of 0.25 M phosphate and 0.1 M NaNO3.  The 
potential was swept at a scan rate of 50 mV/s between 0.8 V and -0.8 V (vs. SCE) for 6 
complete cycles (12 scans).  After electropolymerization, the electrodes were carefully 
washed with 18MΩ water to remove any residual monomer and dried under a gentle 
stream of nitrogen.  Modified Nafion® (10 μL in of a 5% by wt suspension in 100% 
ethanol) was drop-cast on top of the poly(neutral red) (PNR)-modified GC electrodes 
and allowed to dry for 4-6 hours.  These modified electrodes were then soaked in Tris 
buffer solutions (10 mM Tris-HCl, 10 mM KCl, pH 7) containing 10 mM of either NAD+ 
or NMN+ for 18 hours before use.   
Biofuel cell anodes utilizing poly(methylene green) (PMG) as an electrocatalyst were 
prepared similarly to previously published procedures (1) as follows: Methylene green 
was polymerized onto 1 cm2 pieces of Toray paper (TGP-060, E-Tek) by performing 
cyclic voltammetry (6 complete cycles, -0.3 V to 1.3 V) at a scan rate of 50 mV/s in a 
degassed solution containing 0.4 mM methylene green, 0.1 M sodium nitrate, and 10 
mM sodium borate.  The electrode was rinsed and then allowed to dry overnight.  
Enzyme/Nafion® casting solutions (50 μL of 5 wt% by wt. modified Nafion® in 100% 
ethanol combined with 150 μL of pH 7.4 phosphate buffer containing 1 mg/mL enzyme 
and 1 mg/mL NAD+ or 0.5 mg/mL NMN+) were pipetted in 50 μL aliquots onto each 
PMG-modified electrode and allowed to dry for 4-6 hours.  The bioanodes were soaked 
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in a fuel solution (pH 8.0) consisting of 50 mM phosphate, 100 mM sodium nitrate, 50 
mM arabinose, and 1 mM NAD+ or NMN+ overnight before use in the biofuel cell. 
Biofuel Cell Testing: Bioanodes were tested in a biofuel cell apparatus that has been 
previously described (1). The cell consisted of two vertical glass chambers, separated by 
the cathode, which was coated with a Nafion® polymer electrolyte membrane.  The 
upper glass chamber contained the fuel solution, and the bottom chamber was open to 
the air to allow O2 to flow to the cathode.  The cathode material was an ELAT electrode 
with 20% Pt on Vulcan XC-72 (E-Tek).  The cathode was hot pressed to the backside of a 
Nafion® NRE 212 PEM with the catalyst side facing the membrane for 1 minute.  The 
fuel solution was identical to the anode soaking solution, consisting of 50 mM sodium 
phosphate, 100 mM sodium nitrate, 50 mM arabinose, and 1 mM NAD+ or NMN+.  Data 
was collected using a CH Instruments model 810 potentiostat.  The reference and 
counter electrodes were connected to the bioanode, and the working electrode was 
connected to the cathode.  The biofuel cell was allowed to reach a steady open circuit 
potential, after which a polarization curve was taken at a scan rate of 1 mV/s.   
Cyclic Voltammetry and Rotating Disc Voltammetry: Cyclic voltammetry was carried 
out at various scan rates on each electrode in the pH 7 Tris buffer, using a potential 
window of 0.2 V to -0.8 V.  Rotating disc voltammetry was carried out at various 
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rotation rates on each electrode at a scan rate of 10 mV/s.  Electrodes were rotated for 10 
minutes at each rotation rate before the voltammetry was performed.   
 
Results 
We hypothesize that the increased volume of the cofactor binding pocket of AdhD 
afforded by the K249G mutation allows the truncated cofactor to adopt a conformation 
relative to the substrate that favors catalysis. This is supported by the observation that 
both the wild-type enzyme and the H255R single mutant possess very low activity with 
NMN+, while the K249G single mutant exhibits over an order of magnitude increase in 
activity (Table 4.4). Surprisingly, the K249G/H255R double mutant exhibits a further 2-
fold increase in activity with NMN+, and a higher affinity for the truncated cofactor. 
However, the activity of the double mutant with NMN+ is still one to two orders of 
magnitude lower than the wild-type enzyme with its natural cofactor.  
The affinity of the various AdhD enzymes for the minimal cofactor NMN+ is clearly 
lower than for the natural cofactors (Table 4.4). Nicotinamide-dependent enzymes 
typically have a high specificity for either NAD(H) or NADP(H), with NAD(H)-
dependent enzymes typically acting as oxidases while NADP(H)-dependent enzymes 
act as reductases (23). Thus the high specificity allows different enzymes to perform 
both reduction and oxidation reactions simultaneously. As NMN+ lacks the specificity 
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determining half of the molecule, cofactor affinity is significantly decreased. This is 
observed both in the cofactor dissociation constants measured by fluorescence titrations 
and the kinetic parameters (Kia and KA, Table 4.1) from steady-state kinetics. The 
reduced affinity is unlikely to have a large impact in immobilized applications, 
however, due to relatively high enzyme loadings and an increased local concentration 
of cofactor and substrate in the polymeric films. 
As the model substrate for AdhD (2,3-butanediol) was not compatible with the 
Nafion/PMG anode, an alternate substrate (D-arabinose) that displays rapid kinetics 
with the enzyme was used in the biofuel cell. A full kinetic analysis of the engineered 
double mutant AdhD enzyme was performed using both substrates and both the native 
(NAD+) and truncated (NMN+) cofactors (Table 4.1).  In dilute solution, the enzyme 
exhibits a kcat two to three orders of magnitude greater with NAD+ than NMN+ (15 s-1 
with NAD+ vs. 0.018 s-1 with NMN+ for 2,3-butanediol; 65 s-1 with NAD+ vs. 0.55 s-1 with 
NMN+ for D-arabinose). The impact of the cofactor on the Michaelis constants varies 
unexpectedly with the substrate, however. When 2,3-butanediol is the substrate, the 
Michaelis constants for both the cofactor and substrate decrease (KA from 460µM with 
NAD+ to 140µM with NMN+, and KB from 690mM with NAD+ to 17mM with NMN+), 
whereas the Michaelis constants increase when D-arabinose is the substrate (KA from 
480µM with NAD+ to 1100µM with NMN+, and KB from 72mM with NAD+ to 130mM 
with NMN+). Thus, enzyme performance is expected to be much higher with NAD+ as a 
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cofactor, owing both to the two order of magnitude increase in kcat and the significant 
decreases in the Michaelis constants.  
The diffusion coefficients of NAD+ and NMN+ through modified Nafion® and their 
extraction coefficients into the polymer films were determined by cyclic voltammetry 
(CV) and rotating disc voltammetry (RDV). The biofuel cells described later in this 
study utilize poly(methyelene green) (MG) as an electrocatalyst to oxidize the NADH or 
NMNH produced by the enzymes during operation. However, MG cannot catalyze the 
reverse reaction to reduce NAD+, so a different electrocatalyst was needed to measure 
the transport properties of NAD+ and NMN+ through the films. Poly(neutral red) (NR) 
has been shown to be an effective electrocatalyst for the two-electron reduction of NAD+ 
(21, 22),   and was used in this study to determine the rate at which NAD+ and NMN+ 
diffused through the film to the electrode surface. The diffusion coefficients and 
extraction coefficients of NAD+ and NMN+ are shown in Table 4.2, as determined by 
Saveant (24) analysis of the RDE data (Figure 4.4) as well as analysis (25) of the variable 
scan rate CV experiments (Figure 4.2). As seen in the table, NMN+ diffuses through 
modified Nafion® faster than NAD+ by an order of magnitude. This is likely due to the 
smaller size of NMN+, relative to NAD+ (Figure 4.1a,b). NAD+ was shown to have a 
higher extraction coefficient into the modified Nafion® films. This may be due to the 
more hydrophobic nature of NAD+ relative to NMN+, which results from the aromatic 
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adenine group attached to NAD+. Overall, the flux of NMN+ through modified Nafion® 
is higher than NAD+, as expected for a smaller molecule.  
A schematic of the bioanode is shown in Figure 4.1c. Methylene green (MG) is 
polymerized onto the carbon paper electrode to act as a mediator for cofactor oxidation. 
The MG lowers the overpotential required to oxidize the reduced cofactor by ~500 mV 
and produces a greater anodic current as compared to an unmodified electrode (26, 27). 
Even though the double mutant AdhD enzyme had a much lower turnover rate with 
NMN+ in dilute solution, biofuel cells using NMN(H) as a cofactor performed similarly 
to ones using NAD(H) (Figure 4.3, Table 4.3).  The open circuit potential for NAD(H) 
biofuel cells was higher than for NMN(H) fuel cells (0.642 vs 0.593 V), while the 
maximum power densities of the biofuel cells using each cofactor were not statistically 
different (1.52 ± 0.27 vs 1.37 ± 0.24 µW/cm2, respectively). Interestingly, the use of 
NMN(H) resulted in a 40% increase in maximum current density, which suggests an 
improvement in mass transfer for the truncated cofactor.  
 
Discussion 
Although non-natural biomimetic cofactors may possess superior properties for some 
applications, their use is hindered by the fact that they are generally poor substrates for 
wild type enzymes. There currently exists no framework or general rules for the 
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engineering of enzymes to use non-natural cofactors, but the changing of cofactor 
specificity between the two natural cofactors NAD(H) and NADP(H) has been 
extensively researched over the past two decades (28, 29). Interestingly, the same 
mutations that have been identified in some enzymes to broaden or reverse cofactor 
specificity seem to improve activity with non-natural cofactors. This effect has been 
observed both in the Cytochrome P450 studied by Ryan et al. and the alcohol 
dehydrogenase (AdhD) examined in this study. These wild-type enzymes show little to 
no activity with the non-natural cofactors, while some of the cofactor specificity 
mutants are able to use these truncated cofactors with nearly wild-type levels of 
activity. The high specificity of enzymes for their cofactors has evolved so that enzymes 
catalyzing oxidation reactions do not need to be separated from enzymes catalyzing 
reduction reactions. It is therefore not unexpected that relaxing this specificity allows 
the enzymes to become more permissive in accepting non-natural biomimetic cofactors, 
which depending on the rate-limiting step of the reaction, can lead to high levels of 
activity.  
Analysis of the polarization curves obtained with each cofactor provides insight into the 
processes affecting biofuel cell performance. The open circuit potential (OCP) of the fuel 
cell (the y-intercept of the polarization curve), is the cell potential at infinite resistance 
(open circuit), and is dependent on the formal potential of the cofactor at the 
poly(methylene green) electrocatalyst as well as the rate of accumulation of the reduced 
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cofactor at the electrode surface.  The formal potential differences combined with the 
increased turnover rate of the enzyme with the natural cofactor leads to a higher OCP in 
the NAD+ fuel cell. Conversely the limiting current, measured under “short circuit” 
conditions, is predominantly a function of mass transfer within the system. Here, the 
order of magnitude increase in the diffusion coefficient of NMN+ compared to NAD+ 
results in a greater than 40% increase in the limiting current. As current is proportional 
to the number of electrons transferred to the electrode, it follows that the faster 
diffusing NMN(H) can shuttle more electrons between the enzyme active site and 
electrode surface per time than NAD(H). Lastly, the maximum power density is 
dependent on both the kinetic rates of cofactor reduction by the enzyme and cofactor 
oxidation by MG on the electrode surface, as well as mass transfer effects and ohmic 
losses within the system. Surprisingly, the maximum power densities observed with 
NAD(H) and NMN(H) were not statistically different. This suggests that the rate of 
turnover by the enzyme is not limiting in this system; rather performance is dominated 
by mass transfer effects or by the rate of oxidation of the reduced cofactors by MG.  
The use of poly(neutral red) as an electroreduction catalyst to measure the diffusion 
coefficients of the oxidized cofactors through modified-Nafion® may also provide 
insight into the relative rates of oxidation of the reduced cofactors at MG. The rate of 
NMN+ reduction at the PNR modified electrode was found to be much faster than for 
NAD+ (Figure 4.2), as shown by the decreased ∆Ep from 354 mV for NAD+  to 229 mV 
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for NMN+. Given the structural similarities between MG and PNR, it is possible the rate 
of NMNH oxidation by MG may be comparatively higher than that of NADH. While 
the reasons for this are not clear, the presence of the adenine moiety in NAD(H) may 
sterically hinder the nicotinamide group from reaching the surface, and may also cause 
the cofactor to adsorb onto the electrode surface through interactions with MG. As this 
half of the cofactor is absent in NMN(H), the nicotinamide group may be able to more 
freely interact with the MG, promoting charge transfer.  
The present work opens new avenues of research involving electron relay systems, and 
will have important applications in many biocatalysis applications. We have 
demonstrated that the use of the truncated cofactor NMN(H) resulted in similar power 
densities and increased current densities compared to NAD(H), and that the rates of 
cofactor diffusion and cofactor oxidation at the electrode surface are much more 
important than the rate of enzyme turnover. The critical bottleneck in using alternative 
cofactors is the lack of enzymes engineered for altered or broadened cofactor specificity.  
In addition, further improvements to the biomimetic cofactors are also likely to improve 
system performance including stability, redox potential, turnover at the electrode 
surface, and cost. 
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Tables and Figures 
Table 4.1 – K249G/H255R AdhD Kinetic Parameters 
Cofactor kcat (s-1) Kia (µM) KA (µM) KB (mM) 
wt AdhD 
2,3-butanediol 
NAD+ 1.0 ± 0.1 37 ±2 63 ±2 29 ±1 
NMN+ <0.0005 ND ND ND 
K249G/H255R AdhD 
2,3-butanediol 
NAD+ 15 ± 2 11 ± 1 460 ± 60 690 ± 80 
NMN+ 0.018 ± 0.002 880 ± 10 140 ± 20 17 ± 5 
D-arabinose 
NAD+ 65 ± 1 78 ± 3 480 ± 10 72 ± 2 











NAD+ 5.45 (± 0.37) x 10-9  1.15 ± 0.09 
NMN+ 4.32 (± 0.43) x 10-8 0.44 ± 0.05 
 
 
Table 4.3 – Summary of Biofuel Cell Performance 







NAD+ 0.642 ± 0.011 1.52 (± 0.27) x 10-6  1.61 (± 0.36) x 10-5 





Figure 4.1 (a) Structure of the biomimetic cofactor NMN+ and (b) natural cofactor NAD+. 
(c) Schematic of the bioanode. Methylene green mediator is polymerized on carbon 
paper electrode. Enzyme and cofactor are immobilized in TBAB-modified Nafion® on 
electrode surface. A commercially available air-breathing platinum cathode completes 
the fuel cell.  
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Figure 4.2  Representative cyclic voltammograms of NAD+ (A) and NMN+ (B) at a PNR-
modified GC electrode coated with modified Nafion® at a variety of scan rates.  
Conditions: Quiescent solution, room temperature, 10 mM Tris-HCl, 10 mM KCl, 10 
mM NAD+/NMN+, pH 7.0.  Insets: Plot showing linear relationship between current and 




Figure 4.3  Representative polarization curves of biofuel cells using either NAD+ or 
NMN+ as cofactors. Conditions: Quiescent solution, room temperature, 100 mM sodium 




Table 4.4 – Apparent Kinetic Parameters of wt AdhD and Mutants 
 






wt AdhD 0.03 2500 875 1.2 
H255R 0.07 2100 ND 3.3 
K249G 0.8 3800 ND 21 






wt AdhD 85 60 59 140000 
K249G/H255R 180 460 45 40000 
 
Reaction conditions: 50mM glycine, 100mM 2,3-butanediol (pH 8.8), 45°C. Reactions 
were initiated by the addition of NAD+ (1 - 1000 µM) or NMN+ (5 – 3000 µM), and 
monitored at 340nm. Each experiment was run in triplicate, and the data was fit to a 
















Figure 4.4 Representative rotating disc voltammograms of NAD+ (A) and NMN+ (B) at a 
PNR-modified GC electrode coated with modified Nafion® at a variety of rotation rates.  
Conditions: Quiescent solution, room temperature, 10 mM Tris-HCl, 10 mM KCl, 10 
mM NAD+/NMN+, pH 7.0.  Insets: Koutechy-Levich plots showing a linear relationship 
between inverse current and inverse square root of rotation rate.   
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MODULAR EXCHANGE OF SUBSTRATE BINDING LOOPS ALTERS BOTH 
SUBSTRATE AND COFACTOR SPECIFICITY IN A MEMBER OF THE ALDO-KETO 
REDUCTASE SUPERFAMILY§ 
 
Abstract: Substrate specificity in the aldo-keto reductase (AKR) superfamily is 
determined by three mobile loops positioned at the top of the canonical (α/β)8-barrel 
structure. These loops have previously been demonstrated to be modular in a well 
studied class of AKRs, in that exchanging loops between two similar hydroxysteroid 
dehydrogenases resulted in a complete alteration of substrate specificity (1). Here, we 
further examine the modularity of these loops by grafting those from human aldose 
reductase (hAR) into the hyperthermostable AKR, AdhD, from Pyrococcus furiosus. 
Replacement of Loops A and B were sufficient to impart hAR activity into AdhD, and 
the resulting chimera retained the thermostability of the parent enzyme. However, no 
active chimeras were observed when the hAR loops were grafted into a previously 
engineered cofactor specificity mutant of AdhD, which displayed similar kinetics to 
hAR with the model substrate DL-glyceraldehyde. The non-additivity of these 
mutations suggests that efficient turnover is more dependent on the relative positioning 
                                                 
§ A version of this chapter has been submitted to Biochemistry with co-authors Sara Chuang, and Scott Banta. 
EC designed the experiments, performed the experiments, analyzed data, and wrote the manuscript. 
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of the cofactor and substrate in the active site than on binding of the individual species. 
The ability to impart the substrate specificities of a variety of mesostable AKRs into a 
thermostable scaffold will be useful in a variety of applications including immobilized 
enzyme systems for biofuel cells and fine chemical synthesis. 
 
Introduction 
Aldo-keto reductases (AKRs) comprise a large, diverse family of oxidoreductase 
enzymes and are found in nearly every species (2, 3). They share a common (α/β)8-
barrel structure and catalytic mechanism, but some members of the superfamily share 
less than 30% sequence homology. These enzymes bind a nicotinamide cofactor in an 
extended conformation along a cleft that runs through the C-terminal face of the barrel, 
in contrast to the Rossman-fold motif common in other dehydrogenases. Three mobile 
loops on the same face form the substrate binding pocket. The physiological role of 
many of these enzymes is unknown, but they are generally thought to fall into one of 
three classes. The most studied members of this family are mammalian AKRs involved 
in steroid and prostaglandin metabolism (4-6). These enzymes often have long substrate 
binding loops and are highly specific for their substrates. Another well studied class of 
AKRs, the aldose reductases, are involved in the interconversion of glucose to sorbitol 
and have been investigated as drug targets to prevent complications from diabetes (7, 
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8). A third class of AKRs, which have been identified in a wide range of species, have no 
known function (9). The substrate binding loops in these enzymes are often truncated, 
imparting them with fairly broad substrate specificity. Additionally, they have been 
shown to be upregulated in response to stress, leading to the hypothesis that their 
physiological role is of general detoxification, metabolizing various aldehydes and 
ketones to less toxic species (10). 
The advent of high-throughput sequencing has allowed the complete genomes of 
several species to be elucidated, and the sequence data has yielded several putative 
members of the aldo-keto reductase superfamily (11, 12). One of these enzymes, AdhD, 
was identified in the hyperthermophilic archaea Pyrococcus furiosus, and has been 
characterized by our group and others. The enzyme has a strong preference for 
NAD(H) as a cofactor, and oxidizes a range of sugars and alcohols (12, 13). The 
substrate binding loops in this enzyme are significantly truncated compared to AKRs 
identified from other organisms, with the C-terminal loop (Loop C), completely absent. 
This likely contributes to the broad substrate specificity and extreme thermostability of 
the enzyme.  
The importance of the mobile loops in substrate binding and specificity was elegantly 
demonstrated through the creation of several chimeric hydroxysteroid dehydrogenases 
(HSD) where the substrate binding loops from a 20α-HSD were grafted into a 3α-HSD 
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enzyme scaffold (1). Replacement of only Loop A resulted in an enzyme with novel 17β-
HSD activity, while swapping all three substrate binding loops resulted in a complete 
alteration of substrate specificity, with an increase in catalytic efficiency for the 20α-
HSD reaction of 1011 compared to the wild-type 3α-HSD enzyme. 
Based on this impressive work, we decided to investigate a similar strategy to rationally 
alter the substrate specificity of AdhD. In an attempt to improve the activity of AdhD 
with sugars, we created several loop chimeras inserting the substrate binding loops 
from human aldose reductase, which has activity with glucose (7, 14-17). These loop 
chimeras are also compared to and combined with a cofactor specificity double mutant 
of AdhD (K249G/H255R) that exhibits broadened cofactor specificity and improved 
activity compared to the wild-type enzyme (13). A summary of loop chimera constructs 
appears in Table 5.1.  
Whereas the previous work exchanged substrate binding loops between similar 
hydroxysteroid dehydrogenases, the present work investigates exchanging loops 
between two distinct AKRs which share less than 30% sequence homology. While 
AdhD is an extremely thermostable archaeal enzyme with broad substrate specificity, 
human aldose reductase (hAR) is a mesostable mammalian AKR with a specialized 
function. Also, AdhD has a strong preference for NAD(H) as a cofactor, while hAR has 
a strong preference for NADP(H). Thus, in addition to the change in substrate 
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specificity expected due to changing the substrate binding loops, it will also be 
interesting to observe the effects on cofactor specificity and thermostability. 
 
Materials and Methods 
In order to design the AdhD/hAR loop chimeras, sequence and structural alignments 
were performed. Sequence alignments of AdhD (GenBank 1469842) and hAR (GenBank 
AAA51713) were performed using the CLUSTALW tool, and structural alignments of 
AdhD and hAR (PDB 2ACQ) were performed with Yasara. DNA oligos corresponding 
to the hAR substrate binding loops were obtained from IDT DNA, Inc. (Coralville, IA) 
and assembled into the AdhD gene using overlap extension PCR (see SI). PCR 
fragments were doubly digested with NcoI and HindIII and cloned into a similarly 
digested pET-24d vector. All constructs were verified by DNA sequencing.  
AdhD/hAR Loop chimeras were initially expressed in 50ml cultures and purified by 
heating of the cell extracts, as described previously (13). Two constructs, A (wt AdhD 
with Loop A) and D (DM AdhD with Loops A + B), were not well expressed despite 
numerous attempts to optimize the expression and purification of these samples. Thus 
they were not investigated further. Relatively pure protein (estimated > 90% pure by 
SDS-PAGE) was obtained in the heat-stable extract, and was used without further 
purification for initial studies. 
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Large scale expression and purification of wild-type AdhD and mutants followed a 
previously described protocol (13). Typical yields were on the order of 300 - 1200 mg L-1 
of culture, and samples were estimated to be >98% pure by SDS-PAGE.  
The hAR gene was amplified from human placenta QUICK-clone cDNA (Clontech, 
Mountain View, CA) using forward primer 5'-GGTCTGGGGAGCGCAGCAGC-3' and 
reverse primer 5'-TTCGAAGCTTTCAAAACTCTTCATGGAAGGGGTAATCCTT-3’. 
The reverse primer inserted a unique HindIII restriction site (underlined). The purified 
PCR fragment was doubly digested with NcoI and HindIII and ligated into a similarly 
digested pET-24d vector containing an N-terminal RGSHis tag for purification. Ligated 
plasmids were transformed into electrocompetent BLR E. coli (Novagen, Gibbstown, NJ) 
and plated on LB-Kan selection plates. Individual colonies were picked and grown 
overnight in LB medium supplemented with 50 μg ml-1 kanamycin and stored as 
glycerol stocks. Proper insertion of the hAR gene was verified by DNA sequencing.  
Expression and purification of hAR followed a different protocol, as the enzyme is not 
highly thermostable. One liter expression cultures of Terrific Broth containing 50 μg ml-1 
kanamycin were inoculated from an overnight culture, and expression was induced at 
OD600 ≈ 0.6 by the addition of IPTG to 0.2mM. Expression continued for 16h at 37°C with 
agitation. Cells were harvested by centrifugation, and resuspended in 1/10th volume 
Binding Buffer (20mM Tris-HCl, 150mM NaCl, 40mM imidazole, pH 7.5) supplemented 
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with 1x HALT Protease Inhibitor (Fisher Scientific). Cells were lysed by sonication on 
ice for a total of 8 minutes, following cycles of 5 seconds on and 5 seconds off. Cell 
debris was removed by centrifugation for 20 mins at 10000g. Samples were then loaded 
onto a HisTrap column (GE Healthcare, Piscataway, NJ) equilibrated in Binding Buffer. 
After rinsing with 10 column volumes of Binding Buffer, His-tagged hAR was eluted 
with a gradient of 0-100% Elution Buffer (20mM Tris-HCl, 150mM NaCl, 500mM 
imidazole, pH 7.5) over 20 column volumes. hAR eluted in a single peak at an 
imidazole concentration of ~150mM.  Fractions containing hAR were pooled and 
concentrated over a 30kDa centrifugal filter and applied to a Superdex 16/200 gel 
filtration column (GE Healthcare, Piscataway, NJ) equilibrated in 20mM Tris-HCl (pH 
7.5) containing 150mM NaCl. Fractions containing enzyme were pooled and 
concentrated over a 30kDa filter, before being diluted to the desired working 
concentration in 20mM Tris-HCl (pH 7.5). Typical yields were on the order of 30 mg L-1 
of culture, and samples were estimated to be >98% pure by SDS-PAGE. 
All loop mutants were initially screened in a 96-well plate assay. To test for activity in 
the oxidation reaction, 10μl of partially purified enzyme was added to 290μl 50mM 
glycine (pH 8.8) containing 1mM NAD+ or NADP+ and 10mM of the indicated substrate 
in a 96-well UV-transparent microplate. For the reduction reaction, 10μl of partially 
purified enzyme was added to 290μl 100mM sodium phosphate (pH 6.1) containing 
500μM NADH or NADPH and 10mM of the indicated substrate. Plates were incubated 
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at 37°C and imaged under UV light at various time points to monitor the production or 
depletion of reduced cofactor.  
Full kinetic assays were performed on the active enzymes identified by the plate assay. 
For the oxidation reaction, 10μl of the appropriate concentration of purified enzyme 
was added to 290μl 50mM glycine (pH 8.8) containing 5-2000μM NAD+ or NADP+ and 
1-100mM of the indicated substrate. For the reduction reaction, 10μl of the appropriate 
concentration of purified enzyme was added to 290μl 100mM sodium phosphate (pH 
6.1) containing 1-500μM NADH or NADPH and 1-100mM of the indicated substrate. 
Plates were incubated (at 25°C for the reduction reaction, 37°C for the oxidation 
reaction) in a SpectraMax M2 spectrophotometer (Molecular Devices, Sunnyvale, CA) 
and the absorbance at 340nm was followed to monitor the production or depletion of 
NAD(P)H (ε340nm = 6220 M-1 cm-1). Experiments were performed in at least triplicate. 
Kinetic data were fit to the ordered bi-bi rate equation using a non-linear regression 
program (Igor Pro, Wavemetrics, Inc.).  
Cofactor dissociation constants were measured by fluorescence titration, following a 
previously described protocol (18-20). Proper folding of the loop chimeras and 
determination of thermal stability were investigated by CD spectroscopy as described 




A sequence and structural alignment of hAR (PDB ID 2ACQ) with a previously 
generated homology model of AdhD (13) guided the insertion of the hAR binding loops 
into AdhD (Figure 5.1). The structural alignment also identified a short loop in AdhD 
(corresponding to residues 182-184) not present in hAR, which could potentially 
sterically interfere with Loop C and prevent it from properly folding over the top of the 
barrel. Thus additional mutants were generated with this short loop removed (denoted 
∆182-184) to increase the likelihood of Loop C adopting its native conformation. 
Loops were inserted at the genetic level through a series of oligonucleotide primers, 
which were used to PCR fragments of the gene containing the desired loops (see SI). 
These fragments were then reassembled into a full length gene using overlap-extension 
PCR, and cloned into a vector for expression. 
A concern when grafting in the large substrate binding loops from hAR was a decrease 
in the thermostability of the AdhD scaffold. Thus mutants were characterized by CD 
spectroscopy and thermal denaturation experiments. Surprisingly, the impact on 
enzyme stability was minimal, as no change in CD signal was observed from 25°C to 
90°C (data not shown). 
Loop mutants were initially screened in a plate assay. Mutants were tested for their 
ability to reduce DL-glyceraldehyde with NADPH, the model substrates for hAR, and 
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in the oxidation and reduction of 2,3-butanediol and 3-hydroxy-2-butanone 
respectively, the model substrates for AdhD, using both NAD(H) and NADP(H) 
cofactors. Plates were illuminated by UV to visualize the reduced cofactor and 
photographed at regular intervals. A representative image of the plate after 45 minutes 
of incubation is shown in Figure 5.2. At this time point, only hAR showed appreciable 
activity with DL-glyceraldehyde, and clearly had a preference for NADPH over NADH. 
The AdhD double mutant showed the highest activity with 2,3-butanediol and 3-
hydroxy-2-butanone, with little difference apparent between the NAD(H) and 
NADP(H) cofactors. The activity of wt AdhD was lower with these substrates, and a 
marked preference for NAD+ was observed with 2,3-butanediol. hAR also demonstrated 
activity with both 2,3-butanediol and 3-hydroxy-2-butanone, and had a slight 
preference for its preferred cofactor NADP(H) with these model AdhD substrates. 
Interestingly, wt Loops A+B and wt Loops A-C also retained significant activity with 
these substrates, but only when NADP(H) was the cofactor. At longer time points, 
NADPH/DL-glyceraldehyde activity was also observed in these loop chimeras.  
Enzymes that were identified as active in the plate assay were grown in large scale 
expression cultures and purified to homogeneity as described. A full kinetic analysis 
was performed with these samples to allow for fitting to the ordered bi-bi rate equation. 
Parameters are summarized in Table 5.2. While the wt AdhD exhibited very little 
activity with NADPH and DL-glyceraldehyde, the cofactor specificity double mutant 
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had a turnover rate faster than hAR. This was offset by significant increases in the 
dissociation constant and Michaelis constant for NADPH, however, leading to a lower 
catalytic efficiency. The two loop chimeras identified as active in the plate assay 
demonstrated reasonable kinetics with NADPH and DL-glyceraldehyde, but again the 
Michaelis constants were significantly larger than those for hAR or the DM AdhD. With 
the model AdhD substrate 2,3-butanediol, an interesting effect is observed with the loop 
chimeras. Both constructs C and E retained activity with this substrate, but had a strict 
requirement for NADP+ as a cofactor, in contrast to the NAD+ preference exhibited by 
wt AdhD. hAR was also found to have high catalytic rates with this substrate with both 
NAD+ and NADP+, however the catalytic efficiency was much higher with its preferred 
cofactor NADP+. 
The combination of relatively low turnover numbers and high Michaelis constants 
impeded the accurate determination of the full kinetic parameters for the two loop 
chimeras. In order to enable fitting to the ordered bi-bi rate equation, the Kia term was 
set equal to the dissociation constant measured by fluorescence titration (22). As proper 
saturating conditions were not achieved with these mutants, the resulting kinetic 




The modular nature of the aldo-keto reductase substrate binding loops has been 
confirmed in this work, as the AdhD scaffold was successfully imparted with hAR 
activity through a loop grafting approach. Whereas a complete reversal of substrate 
specificity was previously shown to require the exchange of all three substrate binding 
loops, here it appears that only two loops are necessary for activity. Additionally, the 
chimeric mutants studied here maintained the high thermostability of the parent 
enzyme, suggesting that this technique can be used to rapidly stabilize other mesophilic 
AKRs.  
It is difficult to directly compare the catalytic efficiencies of the various enzyme 
constructs due to the large difference in Michaelis constants between enzymes. Thus, 
activities were examined under saturating conditions by looking at the turnover rate, 
kcat. The catalytic rate of wt AdhD is much lower than that of hAR with NADP(H), both 
in the oxidation of the model AdhD substrate 2,3-butanediol and the reduction of the 
model hAR substrate DL-glycerladehyde. The active loop chimeras fall in between, with 
the wt Loops A+B construct having similar activities with both substrates while the wt 
Loops A-C construct has a much faster turnover rate with 2,3-butanediol. Interestingly, 
the DM AdhD has a much higher turnover rate with DL-glyceraldehyde than even 
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hAR, but is comparable to the wt Loops A+B construct with 2,3-butanediol (Figure 
5.3A).  
The steady-state kinetic parameters can also be used to calculate changes in the cofactor 
binding energies relative to the wt AdhD enzyme (23, 24). In the ground state, the loop 
chimeras destabilized the binding of NADP+, while hAR and the previously engineered 
DM AdhD had more favorable binding energies. All constructs except wt Loops A-C 
also demonstrated a decreased free energy of binding with NADPH relative to the wt 
AdhD, which partially explains the improvement in activity observed in these 
constructs (Figure 5.3B). The effect of the loop chimeras is most apparent when 
comparing the transition-state binding energies. Here, both wt Loops A+B and wt 
Loops A-C have a significantly lower transition-state binding energy with DL-
glyceraldehyde/NADPH compared to the wt AdhD, while those with 2,3-
butanediol/NADP+ remain relatively unaffected. (Figure 5.3C) 
In contrast to the previous work, both active loop chimeras (constructs C and E) 
retained activity with their native substrate, but with a strict requirement for the less-
preferred cofactor NADP+. As hAR has been shown to prefer NADP(H), this suggests 
the substrate binding loops can also impact cofactor specificity. In fact, Loop B of some 
AKRs has been demonstrated to take part in cofactor binding through electrostatic 
interactions. The crystal structure of hAR indicates that residue Asp216 on Loop B 
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forms a salt-bridge with Lys262 to form the canonical AKR “seat-belt” over the 
pyrophosphate backbone of the cofactor, thereby locking it into the binding pocket. This 
motif is likely absent in the wt AdhD, as Loop B is significantly truncated and lacks the 
charged residue required to form an electrostatic interaction. Grafting Loop B from hAR 
into AdhD may therefore reconstitute the “seat-belt”, and promote binding and proper 
orientation of the cofactor in the binding pocket. Interestingly, the wt Loops A+B 
construct has the second lowest dissociation constant for NADPH, behind only hAR.  
Given the success in grafting the hAR loops into the AdhD scaffold, it is interesting that 
the same loops grafted into the double mutant AdhD scaffold, which itself possesses 
hAR-like activity, results in an inactive enzyme. As the wt AdhD requires at least Loop 
B of hAR for activity with DL-glyceraldehyde, this supports the hypothesis that cofactor 
binding and orientation provided by the “seat-belt” mechanism is important for 
catalysis. One of the mutations in the double mutant, K249G, removes the lysine residue 
that interacts with the arginine of Loop B. Thus the formation of a “seat-belt” in the DM 
AdhD loop constructs is unlikely, and if this has a detrimental effect on cofactor 




Tables and Figures  
 
Table 5.1 – AdhD / hAR Loop Chimera Constructs 
 
Construct  Enzyme / Loops  
A wt Loop A 
B DM Loop A 
C wt Loops A+B 
D DM Loops A+B 
E wt Loops A–C 
F DM Loops A–C 
G wt Loops A–C + ∆182-184 






Figure 5.1 (A) Homology model of AdhD and (B) crystal structure of hAR (PDB ID 
2ACQ) with substrate binding loops indicated. (C) Sequence alignment of hAR and 




Figure 5.2 Plate Assay of hAR Loop Chimeras 
Partially purified enzyme samples were incubated with 10mM of the indicated 
substrate, and 500µM cofactor (NAD(P)H) in 100mM sodium phosphate, pH 6.1 
(reduction reactions) or 500µM cofactor (NAD(P)+) in 50mM glycine, pH 8.8 (oxidation 






Figure 5.3 Effect of Loop Insertions on Activity and Binding Energy.  
(A) Comparison of turnover rate for AdhD, hAR, and active loop chimeras with DL-
glyceraldehyde/NADPH and 2,3-butanediol/NADP+ as substrates. The value of kcat was 
obtained by fits of kinetic data to the ordered bi-bi rate equation. (B) Change in the 
ground-state cofactor binding energya of constructs with NADPH and NADP+ relative 
to wt AdhD. (C) Change in the transition-state binding energiesb of constructs with DL-
glyceraldehyde/NADPH and 2,3-butanediol/NADP+ relative to wt AdhD.  
a ∆∆Gb = -RTln[(Kia)construct/(Kia)wt AdhD] 
b ∆∆Gb = RTln[(kcat/KA)construct/(kcat/KA)wt AdhD] 
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5’- CGACTCACTATAGGGGAATTGTGAGC -3’ 
HindIII reverse 
5’- ATCTCAGTGGTGGTGGTGGTG -3’ 












Loop B reverse 
5’- GTTTCGCCCACGGGCGATCCGGCTTTTCTAGAGGTGTGTACGCCATTAATGC -
3’ 











5’- ATCAAGTTAAATACTCAGTGTGGCCCGAAACTACAGGACTTCTCG -3’ 
∆182-184 reverse 
5’- AAGTCCTGTAGTTTCGGGCCACACTGAGTATTTAACTTGATTTGC -3’ 
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In this work we describe our efforts to engineer a general dehydrogenase enzymatic 
scaffold for immobilized systems and industrial applications. The ideal scaffold would 
be inexpensive to make and purify, stable, readily immobilized, able to use inexpensive 
cofactors, and easily engineered for activity with a variety of substrates. To meet these 
goals, we have selected a thermostable alcohol dehydrogenase, AdhD, from Pyrococcus 
furiosus as the basis for our engineering efforts. The hyperthermophilic nature of this 
organism requires that all of its constituent proteins, including AdhD, remain well-
folded and active under extreme conditions. Thus the inherent thermostability of our 
scaffold protein provides many benefits in addition to long active lifetimes in 
immobilized systems. First, it allows the enzyme to be easily purified from a mesophilic 
host. Combined with the high expression levels achievable in E. coli, large amounts of 
purified protein can be quickly and inexpensively obtained by heating the cultures and 
removing the denatured endogenous proteins and cell debris by centrifugation. Next, it 
has been shown that thermostable proteins are more tolerant to mutations and thus 
more amenable to protein engineering and mutagenesis (1). As we envision extensively 
engineering this scaffold for a range of applications, a high intrinsic stability will allow 
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a more thorough exploration of sequence space while maintaining a well-folded 
structure. 
In Chapter 2, we addressed the problem of enzyme immobilization through the fusion 
of protein cross-linking domains, thereby functionalizing the enzyme for self-assembly. 
Importantly, we have demonstrated that these fusions minimally affect the kinetic 
properties and thermostability of the enzyme, and that a robust hydrogel structure 
persists over a wide temperature range. The general nature of these cross-linking 
domains allows for the creation of mixed macrohomogenous hydrogels, and may find 
utility in the design of clustered enzyme systems, such as synthetic metabolic pathways.  
In Chapter 3, we studied the cofactor specificity of Pyrococcus furiosus AdhD and 
engineered a highly active double mutant with broadened specificity. A detailed 
analysis of the cofactor binding mechanism using steady-state and pre-steady state 
kinetic techniques revealed a novel transient upon cofactor binding which has not been 
previously observed in the aldo-keto reductase superfamily. This kinetic analysis also 
allowed us to calculate the microscopic rate constants corresponding to each step in the 
cofactor binding mechanism and assess the impact of the mutations on binding and 
catalysis.  
The relaxed specificity of the highly active double mutant engineered in Chapter 3 
allowed the enzyme to utilize a truncated nicotinamide cofactor for catalysis. In Chapter 
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4, we demonstrated the benefits of utilizing a minimal cofactor in immobilized systems 
through the creation of an enzymatic bioanode for the oxidation of D-arabinose. Fuel 
cells constructed with the double mutant AdhD using either NAD(H) or NMN(H) as a 
cofactor exhibited similar maximum power densities, despite a two order of magnitude 
decrease in the activity of the enzyme with NMN+. Additionally, the fuel cell 
constructed with the minimal cofactor exhibited a 40% increase in the maximum current 
density, suggesting that significant gains in performance can be obtained through 
increases in the rate of cofactor diffusion. 
Finally, in Chapter 5, we explore strategies to engineer novel substrate specificities into 
our designed scaffold. One approach to altering the substrate specificity of enzymes is 
through the exchange of substrate binding loops. As this has previously shown to be 
effective in two closely related members of the AKR superfamily, we decided to apply 
this method to AdhD. In an attempt to improve the activity of the enzyme with sugars, 
we grafted in the substrate binding loops from another AKR, human aldose reductase. 
Even though the two enzymes share less than 30% sequence homology, replacement of 
two of the substrate binding loops was sufficient to impart hAR activity on AdhD. It is 
interesting to note that these mutations were not additive with the previously 
engineered cofactor specificity mutant, as grafting the same substrate binding loops 
onto the double mutant AdhD (which itself exhibited hAR activity) resulted in an 
inactive enzyme. This suggests that cofactor and substrate binding cannot be altered in 
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a completely independent fashion, and this will be important to keep in mind for future 
engineering efforts. We hypothesize that this lack of activity is due to improper 
positioning of the substrate relative to the cofactor in the active site, and not due to lack 
of binding of either molecule. As the K249G mutation increases the volume of the 
cofactor binding pocket (and presumably the conformational flexibility of the bound 
cofactor), the catalytic rate enhancement observed in these mutants can be explained by 
a more favorable positioning of the nicotinamide head group within the active site.  
The wide range of substrate specificities exhibited by members of the AKR superfamily 
could potentially be accessed through this modular loop swapping approach. However, 
it is likely that substrate specificities will be desired beyond those of known AKRs. 
Thus, a more general approach to identifying and optimizing scaffolds with novel 
activities is required. 
 
Directed Evolution of Catalytic Activity1 
Directed evolution of peptides or proteins with high affinity for a ligand is relatively 
straightforward, and along with recent developments in selection strategies, binders 
with picomolar affinities are readily attainable (2, 3). Generally, these selection 
                                                 
1 Note that directed evolution experiments also require a genotype-phenotype linkage. As a wide range of techniques 
for accomplishing this have been described, it will not be further discussed here. 
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strategies involve immobilizing the target ligand and passing a library of mutants over 
it. Thus proteins with affinity to the target are immobilized and retained while non-
functional proteins are washed away. Successive rounds of mutagenesis and selection 
can be combined to identify high affinity binders, and further improvements in affinity 
may be obtained by selecting for a slow off-rate (2). Currently, protein engineering 
techniques have yielded binders with femtomolar ligand affinities, far exceeding those 
of the best natural binders (4).  
Extending these techniques to obtain novel or improved enzymes has proved 
challenging, however, as it is much more difficult to identify mutants for improved 
catalytic activity. These reactions generally involve multiple molecules, and require 
precise positioning and a specific environment in the active site. Numerous approaches 
have been developed to identify mutants with improved activity, with varying levels of 
success.  
The simplest and lowest-throughput method is to screen all mutants individually for 
catalytic activity. The efficiency of this process is highly dependent on the sensitivity of 
the assay, and is generally limited to examining a few thousand mutants. Thus, this 
technique is most commonly used to select improved mutants after site-directed 
mutagenesis of a few key amino acids. Since an efficient directed evolution experiment 
 182 
requires exploration of a large region of sequence space (libraries of 1011 - 1014 are not 
uncommon), a high-throughput selection step is preferred.  
Any enzyme that can be directly linked to cell survival provides a useful selection 
scheme. Usually, these in vivo selections complement a function that has been knocked 
out (an auxotroph), or provide resistance against a toxin or synthesize a substance 
essential for growth. Unfortunately, the in vivo nature of the selection severely limits the 
scope of reactions that can be selected for, and often the cells find alternate ways of 
generating the desired phenotype. For example, a common result of increased selection 
pressure is increased expression levels of the enzyme rather than increased catalytic 
efficiency (5). 
Several indirect selection protocols have been developed on the basis of binding to 
substrate, product, or transition state analogues (TSA). The latter takes advantage of 
Pauling’s theory that an enzyme stabilizes a transition state, and thus has much higher 
affinity for the transition state than for the substrates or products (6). Drawing on 
previous successes, researchers attempted to synthesize stable transition state analogues 
that would mimic the geometry and charge distribution of the transition state and 
evolve high affinity binders towards them. This technique was successfully used to 
evolve an antibody with catalytic activity, but the observed reaction rates were quite 
low (7). 
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A similar approach using a specially designed suicide substrate has also been 
developed. Here, a relatively non-reactive substrate analogue is transformed by the 
enzyme into a reactive inhibitor, thereby irreversibly blocking the enzyme. Thus active 
enzymes become covalently bound to the inhibitor and can be readily selected if the 
inhibitor is labeled with an affinity tag. Fast kinetics can be selected for using a limiting 
concentration of inhibitor and reacting for a short time. This technique has been 
successfully used to select proteins with β-lactamase activity from a mock library (8). 
Both of these indirect selection techniques (TSAs and suicide substrates) are severely 
limited by the availability of the appropriate molecule. Their design is not trivial, and 
the efficiency of each technique hinges on the molecule accurately representing the 
desired reaction mechanism. Furthermore, catalytic activity is usually limited by 
mutations that favor the selection step. For example, a suicide substrate may select for 
nucleophiles in the active site that are more reactive with the inhibitor, but do not 
necessarily lead to increased catalytic activity (5). 
These limitations have motivated the development of novel methods to directly select 
for catalytic activity. This type of selection is most easily performed for enzymes that 
catalyze bond formation or breakage. A compelling example is the recent evolution of 
novel RNA ligases from a partially randomized zinc-finger scaffold. Active ligases 
created a covalent linkage between a linked mRNA tail and an immobilized RNA 
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target, enabling efficient recovery. The resulting ligases exhibited a rate enhancement 
for the ligation reaction of greater than 2 x 106 (9). Some metallo-enzymes can also lend 
themselves well to direct selection. Enzymes can first be inactivated by extraction of the 
catalytic metal ion with EDTA and selected based on binding to a substrate. Active 
enzyme can then be selectively eluted upon addition of the metal ion and the 
conversion of the substrate to product, to which the enzyme has a lower affinity (10). 
Another approach has been described in which in vitro compartmentalization is used to 
label microbeads with a single gene and multiple copies of its protein product. The 
microbeads are then re-emulsified with a tagged substrate, and after incubation the 
substrate and product are coupled to the beads. Microbeads with active enzyme are 
then fluorescently labeled with an anti-product antibody and selected using flow 
cytometry (11). Again, there are a number of drawbacks to these approaches and their 
application is limited to specific cases.  
Thus no “best” way of evolving catalytic activity has been identified, but the periodic 
successes indicate the selection step should be based on the properties of the enzyme 
you are trying to optimize. As such, we envision taking advantage of the reaction 
mechanism and unique structure of the AKR superfamily to evolve enzymes with novel 
specificities. 
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Kinetic Based Enzyme Capture 
Immobilized cofactors have been used extensively for affinity chromatography in an 
attempt to purify cofactor-dependent enzymes. The addition of a non-reactive substrate 
analogue to the enzyme solution prior to affinity chromatography has been shown to 
greatly increase the specificity of this purification step, and enzymes can be selectively 
purified based on their substrate specificity (12). This kinetic based enzyme capture 
(KBEC) technique takes advantage of the ordered bi-bi kinetic mechanism shared by a 
large number of enzymes, including dehydrogenases, wherein the cofactor binds first 
and leaves last. In these enzymes, the substrate binding site is usually spatially located 
above the cofactor, preventing the cofactor from dissociating while the substrate is 
bound. Thus the presence of a saturating concentration of substrate analogue in 
solution “locks-on” the enzyme to the cofactor such that enzymes not specific to the 
cofactor/substrate combination are washed away. Enzymes non-specifically bound to 
the immobilized cofactor can also be competitively eluted using soluble fragments of 
NAD(P)(H) (i.e. 5’-AMP). This technique has been extensively characterized and 
optimized for several dehydrogenase enzymes with regards to immobilization 
chemistry, reaction conditions, and substrate analogues (13-15). Additionally, KBEC has 
been demonstrated to be powerful enough to purify yeast alcohol dehydrogenase from 
crude cell extracts in a single bioaffinity chromatographic step (16). 
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To achieve the final goal of being able to rapidly evolve novel substrate specificities into 
our designed scaffold, we have explored the use of KBEC as a selection step for directed 
evolution. In this case, a library of enzyme mutants would be passed over an 
immobilized cofactor column in the presence of a substrate or substrate analogue. 
Mutants that bound could then be released upon a (pH, temperature, etc) shift to 
conditions that promote catalysis, or through competition with the desired substrate. 
The duration and stringency of the wash and elution steps could be modulated over 
successive rounds to increase the selectivity and activity of the recovered mutants.  
As a proof of concept, we have attempted several mock enrichments using various 
fluorescently labeled enzyme constructs. While we have been able to repeat the KBEC 
results of O’Flaherty et al. with yeast alcohol dehydrogenase (YADH) (16), identifying 
conditions for the specific binding and elution of AdhD has proven difficult.  
While immobilized cofactor matrices of various chemistries are commercially available, 
we have obtained superior results with homemade preparations. The nicotinamide 
cofactors can be readily linked through the adenine amine to epoxy-activated Sepharose 
beads under slightly basic conditions. Immobilized cofactor columns prepared in this 
fashion have a higher binding capacity for YADH than commercial preparations, and 
linking at this position ensures enzyme accessibility. As AKRs bind the cofactor in an 
extended conformation, the adenine indol sits in a cleft at the edge of the α/β barrel and 
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a linker attached at this position would likely have a minimal impact on binding affinity 
(Figure 3.1). Indeed, cofactors attached at this position seem to be accessible to both 
YADH and AdhD, as both enzymes are able to use the immobilized cofactors for 
catalysis. Additionally, preparations of immobilized reduced cofactor can be prepared 
in this manner to examine the effect of charge and cofactor oxidation state on KBEC 
efficiency.  
We first examined the salt concentration and ionic strength of the binding and elution 
buffers to minimize non-specific interactions. Under low salt conditions, we observed a 
significant amount of non-specific binding to the cofactor resin, which could be 
reversed upon the addition of a high salt buffer. Several methods were attempted to 
titrate the ionic strength for selectivity, but no optimum was found. We were able to 
identify conditions where wt AdhD could be enriched from a mixture with the double 
mutant enzyme, but as this was shown to be independent of the “locking-on” ligand 
and only on cofactor binding, it would not be a useful selection scheme (Figure 6.1).  
We have also examined a variety of “locking-on” ligands for binding and selectivity. As 
we have been unable to identify an inhibitor for AdhD, a range of molecules similar to 
its preferred substrate were tested. Some success was seen using a combination of 
immobilized oxidized cofactor (NAD(P)+) and the preferred substrate for the reduction 
reaction, 2,3-butanedione. However, the elution peaks were extremely broad, and use of 
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the diketone presented some experimental difficulties due to its reactivity and intrinsic 
fluorescence.  
Despite our limited success with mock selection experiments, this technique may still 
prove valuable as a directed evolution selection step. The broad substrate specificity 
and poor affinities demonstrated by the wild-type and double mutant constructs may 
preclude their selection using this technique, but it is possible that enzymes with high 
specificities to desired substrates could still be obtained from a randomized library. 
Thus this technique is worthy of continued research, as few alternatives yet exist for the 





Figure 6.1 Chromatogram of fluorescently labeled wt AdhD and K249G/H255R AdhD  
Conditions: 1 ml NADP+-Sepharose column at 25°C, equilibrated in 20mM sodium 
phosphate (pH 7.0) containing 20-1000mM NaCl (blue dashed line) and indicated 
ligands. Double mutant AdhD elutes in the protein breakthrough peak, while wt AdhD 
is retained. A salt gradient is used to elute bound enzyme. Additional double mutant 
AdhD elutes at ca. 190 mM NaCl, while a significant wt AdhD peak is observed ca. 240 
mM NaCl. The observed elution behavior was later shown to be independent of the 
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